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Masters endurance athletes who train and compete in organised competitive 
endurance events, appear to take longer to recover after muscle-damaging 
exercise than younger athletes. A reduced sensitivity to increase skeletal muscle 
protein synthesis (MPS) in response to the anabolic stimuli of protein and exercise 
may be contributing to the slower repair and remodelling of muscle fibres. This 
decreased stimulus for MPS negatively affects recovery in this older cohort of 
athletes, although evidence supports the notion that the ingestion of a higher dose 
of protein than the current recommendation of 20 grams, post muscle-damaging 
exercise, demonstrates improvements in muscle function of male masters 
triathletes. However, the efficacy for a higher protein intake in female masters 
endurance athletes has not been established.  
Chapter 2 investigates the effects of ingesting a higher acute dose of protein (40 
g) compared to the current recommended dose (20 g) on muscle recovery 
following exercise-induced muscle damage in older female (≥48 y) endurance 
runners. The study assessed muscle recovery by measuring isometric maximal 
voluntary contraction of the knee extensors, peak countermovement jump height, 
perceived muscle soreness, and flexibility prior to, and at 3 and 24 hours following 
a downhill running protocol, used to elicit muscle damage. The study recruited six 
well trained female endurance runners, 48 years of age and older (mean ± SD: age; 
52 ± 5.6 y, body mass; 61.4 ± 6.2 kg) to take part in three downhill running trials,  
each separated by one week. Participants consumed one of three energy matched 
(1190 kJ) recovery beverages immediately following the run. Beverage 
composition was either a 70 g carbohydrate placebo or one of two protein 
supplements; 20 g of protein and 50 g of carbohydrate, or 40 g of protein and 30 
g of carbohydrate. The 40 g of protein had a likely small beneficial effect compared 
to the placebo (ES = 0.24 ± 0.5) and 20 g of protein (ES = 0.25 ± 0.29) for improving 
maximum voluntary contraction from baseline to 24 hours. The 40 g of protein 
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had a likely small beneficial effect for improving countermovement jump height 
compared to 20 g of protein from baseline to 3 hours (ES = 2.9 ± 4.9), and to 24 
hours compared to the placebo (ES = 0.32 ± 0.39) and 20 g of protein (ES = 0.27 ± 
0.19). The 40 g of protein had an unclear effect on muscle soreness and flexibility. 
The findings of this current study suggest that the acute ingestion of 40 grams of 
whey protein isolate following muscle-damaging exercise, had a small beneficial 
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The format of this thesis is presented in the style of an individual journal article, 
and consequently, some information may be repeated. The thesis is comprised of 
three chapters. Chapter One contains a review of literature and introduces the 
reader to aging effects on skeletal muscle slowing recovery in masters athletes as 
well as the concept of protein supplementation. Chapter Two focuses on the 
effects of acute protein supplementation improving recovery in older female 
endurance runners and is presented in the style of an individual journal article. 
The final Chapter Three summarises the overall finding from the experimental 
study included in this thesis and provides both practical applications and 
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During recent decades, an increasing number of masters athletes have been 
participating in endurance running events, including the half marathon, marathon, 
and ultras (events ≥50 km) (Knechtle, Rüst, Rosemann, & Lepers, 2012; Lepers & 
Stapley, 2016). A masters athlete is “an individual who systematically trains and 
competes in organised forms of competitive sport specifically designed for older 
adults” (Reaburn & Dascombe, 2008, p. 31),  and for the purpose of this review is 
defined as 45 years (y) of age or older. 
Endurance running has been shown to induce muscle damage, particularly the 
eccentric loading of downhill running (Brisswalter & Nosaka, 2013). While the 
magnitude of muscle damaged has been reported to be similar between masters 
athletes and their younger counterparts, research suggests that masters athletes 
take longer to adapt to and recover from the muscle damage (Borges, Reaburn, 
Driller, & Argus, 2016; Brisswalter & Nosaka, 2013; Easthope et al., 2010). A slower 
recovery time has serious implications for the masters athlete, with the potential 
of forcing the athlete to progressively reduce the intensity and frequency of 
training sessions, limiting adaptations and ultimately performance (Barnett, 2006; 
Bishop, Jones, & Woods, 2008; Fell & Williams, 2008). 
Masters female endurance runners are an understudied (Costello, Bieuzen, & 
Bleakley, 2014) yet distinct population, with slower recovery times following 
exercise induced muscle damage (EIMD). This is potentially due to the aging 
effects on muscle, namely the hormonal effects (Enns & Tiidus, 2010), and 
‘anabolic resistance’ to muscle protein synthesis (MPS) (Breen & Phillips, 2011). 
Anabolic resistance is the impaired ability of aging muscle to increase protein 
synthesis in response to the anabolic stimuli of protein and exercise (Cuthbertson 
et al., 2005; Dickinson, Volpi, & Rasmussen, 2013). To overcome this reduced 
sensitivity to the synthesis of new muscle proteins, research indicates that a higher 
dose than the recommended 20 g of protein is needed (Dickinson et al., 2013); it 
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has been shown that 20 g near maximally stimulates MPS in younger men (Witard 
et al., 2014). Information available from dose response studies of dietary protein 
to MPS indicate that ingesting ~40 g of protein after resistance exercise in 
untrained older men can near maximally stimulate MPS (Robinson et al., 2012; 
Yang, Breen, et al., 2012). This dose should also support the facilitation of optimal 
repair and remodelling of skeletal muscle and therefore enhance recovery 
following EIMD.  
The primary aim of this review is to assess if a higher acute protein intake (40 g) 
post muscle-damaging exercise can improve recovery in older female endurance 
runners.  
The first section of this review provides an understanding of EIMD, the importance 
of optimising recovery between training bouts for the endurance athlete, and 
evidence for attenuated recovery in masters athletes after EIMD. Following this is 
a discussion on the effects of aging on skeletal muscle in attenuating recovery in 
older female endurance runners and how anabolic resistance to MPS can be 
overcome. Lastly, given the current lack of evidence regarding protein 
supplementation to improve recovery after EIMD in older athletes, appropriate 
studies in younger populations are critically reviewed and placed in context for the 
older female endurance runner.  
Section One - Exercise induced muscle damage and recovery 
Exercise induced muscle damage has been an area of research since the 1900s, 
with growing interest over the last decades as to the proposed mechanisms of 
muscle damage and the recovery process (Hyldahl & Hubal, 2014). EIMD has a 
direct impact on an athlete’s capacity to train, with adequate recovery 
fundamental for maximising training induced adaptations and performance (Fell 
& Williams, 2008). Research suggests that in older male endurance athletes 
recovery time may be delayed after EIMD compared to their younger counterparts 
(Borges et al., 2016). 
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Mechanisms, symptoms and severity of EIMD  
EIMD is caused primarily by eccentrically biased exercise where the muscle 
lengthens while trying to contract to resist the force of gravity (Douglas, Pearson, 
Ross, & McGuigan, 2017). The exact underlying mechanisms responsible for EIMD 
remain unclear (Paulsen, Ramer Mikkelsen, Raastad, & Peake, 2012). However, 
mechanisms associated with muscle damage can be separated into a primary and 
secondary phase (Owens, Twist, Cobley, Howatson, & Close, 2018). The primary 
phase is a result of the mechanical damage occurring during exercise, including 
damage and disruption to the sarcomeres from the high tension on the muscle 
myofibrils (Clarkson & Hubal, 2002; Howatson & Someren, 2008), and dysfunction 
of excitation-contraction coupling (Howatson & Someren, 2008; Owens et al., 
2018). Secondary damage involves the loss of Ca2+ regulation, which causes 
further damage to the myofibrils (Peake, Nosaka, & Suzuki, 2005), followed by an 
inflammatory response, required for removal of the damaged tissue and starting 
the repair and remodelling of skeletal muscle (Chazaud, 2016; Peake et al., 2005).  
Endurance running has a large component of eccentric contractions, with damage 
most severe from downhill running (DHR) due to the higher mechanical stress on 
the muscles (Easthope et al., 2010). This damage is characterised by a set of 
specific symptoms following the exercise bout. 
The symptoms of EIMD typically include a loss of muscle force generating capacity, 
soreness, swelling of the affected limb/s, a decrease in range of motion, and 
leakage of muscle proteins (e.g. creatine kinase, myoglobin) into the blood 
(Douglas et al., 2017; Howatson & Someren, 2008; Peake et al., 2005). Symptoms 
present immediately after the initial exercise bout, with some symptoms present 
for up to two weeks, depending on the extent of damage (Owens et al., 2018).  
The severity of muscle damage determines the time taken to recover, with muscle 
damage largely dependent on the choice of exercise protocol (Owens et al., 2018). 
Greater damage is induced from eccentric contractions that are of faster velocity, 
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higher intensity, longer muscle lengths or a greater number of contractions 
(repetitions) (Peake et al., 2005). The damage response is also modified by the 
large variation between individuals in response to EIMD (Owens et al., 2018; 
Paulsen et al., 2012). Genetic variability among individuals (Baumert, Lake, 
Stewart, Drust, & Erskine, 2016), training status, age, and hormones (Owens et al., 
2018) modify the damage response. The greatest modifier is the repeated bout 
effect (RBE), defined as the ability of skeletal muscle to adapt so that it is protected 
against damage in subsequent exercise bouts (Hyldahl, Chen, & Nosaka, 2017; 
McHugh, 2003). Irrespective of differences in the extent of muscle damage, 
adequate recovery is a fundamental component of an athletes training program, 
as muscle soreness and loss of muscle function impact directly on an athlete’s 
ability to maintain a training program.  
Optimising recovery and the proposed delayed recovery in masters athletes after 
EIMD 
Optimising recovery between bouts of endurance training is essential to maximise 
training induced adaptations and improve performance in any age endurance 
athlete, yet there is a paucity of information and understanding on the recovery 
kinetics of the masters endurance athlete after EIMD (Borges et al., 2016). 
Women,  in particular are underrepresented in this research. Much of the seminal 
research has been conducted using animal models, with indications that advancing 
age does not increase susceptibility to damage but does lead to longer recovery 
periods (Fell & Williams, 2008). Two studies have been undertaken in male 
endurance athletes that support the findings from animal models (Easthope et al., 
2010; Sultana et al., 2012).  
Recovery over a 72 hour (h) period was compared between 13 older (50 ± 6  y) and 
10 younger (31 ± 7 y) ultra-endurance runners of a similar performance level  after 
a 55 km trail race (Easthope et al., 2010). Fatigue levels after the race were similar, 
but the older athletes required an additional 24 h for maximal voluntary 
contractions (MVC) of knee extensors to return to baseline. A later study 
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measured the recovery of well-trained male triathletes after an Olympic distance 
triathlon (Sultana et al., 2012); in 10 masters (52 ± 10 y) and 9 younger (28 ± 6 y) 
athletes. While there was little difference in recovery of MVC of knee extensors at 
24 h following the triathlon in either group, running speed in the masters group 
was significantly reduced at ventilatory threshold 2 (linked strongly with running 
performance) at 24 h post-exercise, compared to younger athletes. These studies 
suggest that after EIMD, the extent of muscle damage is comparable between 
younger and older athletes, but the recovery time is slower for the repair and 
regeneration of muscle tissue. 
A slower rate of recovery in masters endurance runners after muscle-damaging 
exercise has the potential of forcing the athlete to progressively reduce the 
intensity and frequency of training sessions, thereby slowing and limiting 
adaptations and performance (Bishop et al., 2008; Brisswalter & Nosaka, 2013; Fell 
& Williams, 2008), and possibly increasing the risk of injury (Borges et al., 2016). It 
is therefore important, to identify the key factors for the delayed recovery and 
possible means by which they can be modified to enhance the recovery time. 
Section Two - Factors contributing to slower recovery  
A number of factors likely contribute to the attenuated recovery of masters 
endurance athletes after EIMD, however this review concentrates on the slower 
recovery in older female endurance runners. Of relevance to the older female 
endurance runner are the hormonal effects on muscle, and anabolic resistance to 
MPS in this population (Doering, Reaburn, Phillips, & Jenkins, 2016).  
Hormonal effects on muscle  
Aging is associated with a natural decline in sex hormones, however, the declining 
levels of oestrogen, specifically that of estradiol-17β (referred to for ease of 
communication in this review as oestrogen), may significantly impact on recovery 
due to its proposed protective and anabolic effect on skeletal muscle (Enns & 
Tiidus, 2010). Oestrogen acts as an antioxidant, limiting damage to muscle fibres, 
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and works to stabilise the sarcolemma which reduces disruption to the membrane 
in the primary damage phase (Kendall & Eston, 2002). In the secondary phase, 
oestrogen attenuates muscle tissue inflammation, reducing the infiltration of 
neutrophils to the damage site (Tiidus, Lowe, & Brown, 2013). Oestrogen also has 
an anabolic effect, promoting skeletal muscle repair and regeneration via 
enhanced satellite cell activation and proliferation, needed for the repair and 
regeneration of skeletal muscle (Enns & Tiidus, 2010; Velders & Diel, 2013).  
Declining oestrogen levels correspond with the menopause transition beginning 
in the mid to late 40s (Burger, Hale, Robertson, & Dennerstein, 2007; Messier et 
al., 2011), with levels continuing to decline more rapidly during menopause in the 
late 40s to early 50s. By post-menopause oestrogen is generally at minimal 
concentrations in most females (Hansen, 2018). These lower concentrations of 
oestrogen have important implications for female endurance runners such as an 
increased susceptibility to muscle damage and an attenuated ability to promote 
skeletal muscle repair and regeneration. While low oestrogen levels likely 
contribute to the proposed delayed recovery in this cohort, the anabolic resistance 
to MPS likely exerts an effect of greater magnitude. 
Anabolic resistance to muscle protein synthesis with aging  
Aging is characterised by a gradual loss of skeletal muscle mass beginning in the 
fourth or fifth decade of life due to an imbalance between muscle protein 
synthesis and muscle protein breakdown, referred to as sarcopenia (Wall, Cermak, 
& Loon, 2014). It has been established that basal skeletal muscle net balance in 
older adults is not compromised (Markofski et al., 2015), and that this loss of 
muscle mass is primarily due to an impaired ability of skeletal muscle to increase 
muscle protein synthesis in response to anabolic stimuli of protein/amino acids or 
exercise, termed “anabolic resistance” (Breen & Phillips, 2011; Cuthbertson et al., 
2005; Dickinson et al., 2013). Anabolic resistance is directly linked to sarcopenia 
and is also suggested to be a main factor contributing to the attenuated recovery 
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in masters athletes after EIMD compared to their younger counterparts (Doering, 
Jenkins, et al., 2016; Doering, Reaburn, et al., 2016).  
Mammalian target of rapamycin complex 1 and muscle protein synthesis 
A critical regulator of muscle protein synthesis is the mammalian target of 
rapamycin complex 1 (mTORC1) pathway (Drummond et al., 2009). The mTORC1 
is activated independently in response to two main stimuli, muscle contraction 
and protein/amino acid feeding, through different upstream signalling pathways 
(Dickinson et al., 2011; Drummond et al., 2009). When protein feeding follows a 
bout of exercise, muscle contraction and protein feeding work synergistically to 
increase mTORC1 activation than either one alone (Moore et al., 2009). An 
increase in mTORC1 kinase activity leads to an increase in the phosphorylation of 
two key downstream effectors, eukaryotic initiation factor 4E binding protein (4E-
BP1) and ribosomal S6 Kinase 1 (S6K1). These two effectors contribute significantly 
to the regulation of translation initiation and ultimately protein synthesis in 
skeletal muscle (Wang & Proud, 2006).  
Evidence for a significant role of the mTORC1 signalling pathway in promoting MPS 
after endurance exercise comes from several studies in younger male athletes. 
These studies have found that when carbohydrate (CHO) is co-ingested with 
protein (P) after endurance exercise, there is an increased activation of mTORC1 
and its downstream effectors (Breen et al., 2011; Cogan et al., 2018; Rowlands et 
al., 2014; Rowlands et al., 2011), along with MPS (Breen et al., 2011; Howarth, 
Moreau, Phillips, & Gibala, 2009; Rowlands et al., 2011), than CHO alone. The 
efficacy for carbohydrate-protein (CHO-P) over CHO alone for increasing MPS has 
been found with CHO-P ingested at 1.2 g.kg-1-0.4 g.kg-1 and 25 g-10 g and 180 g-
23 g. For example, when trained male cyclists (29 ± 6 y) consumed a CHO-P 
beverage containing (25 g CHO-10 g P) compared to a CHO only beverage after 
cycling for 90 minutes, mTORC1 phosphorylation and its downstream effector 
S6K1 were greater at 4 hours post-exercise, and myofibrillar protein synthesis 
rates were ~35% higher (Breen et al., 2011).  
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In older (~70 y) adults however there is substantial evidence for an impaired ability 
to fully activate the mTORC1 pathway in response to the anabolic stimuli 
(Cuthbertson et al., 2005; Kumar et al., 2009). As such, it is proposed to be a key 
underlying mechanism for ‘anabolic resistance’, leading to lower rates of skeletal 
MPS in older populations (Dickinson et al., 2013). 
Anabolic resistance to protein ingestion, exercise or both 
Anabolic resistance to MPS with aging has been reported in response to protein 
ingestion in the rested state (Cuthbertson et al., 2005; Katsanos, Kobayashi, 
Sheffield-Moore, Aarsland, & Wolfe, 2005; Wall et al., 2015), after resistance 
exercise in the fasted state (Fry et al., 2011; Kumar et al., 2009), and when protein 
is ingested in close proximity to a bout of exercise (Doering, Jenkins, et al., 2016; 
Durham et al., 2010; Farnfield, Breen, Carey, Garnham, & Cameron - Smith, 2012). 
   Anabolic resistance to protein ingestion at rest 
Evidence for anabolic resistance to protein ingestion at rest comes from a study of 
24 healthy elderly men (70 ± 6 y) and 24 younger (28 ± 6 y) men who consumed 
10 g essential amino acids (EAA) (~20 g P). The older men had significantly lower 
phosphorylation of mTORC1 and its downstream effector S6K1 (Cuthbertson et al., 
2005). Katsanos and colleagues (2005), investigated the differences between 
muscle protein accretion in older (68 ± 3 y) and younger (31 ± 2 y) men and 
women. With ingestion of a small bolus of  ~7 g EAA (15 g P) muscle protein 
accretion was reduced in the older group (Katsanos et al., 2005). In a large cohort 
study of 35 young (22 ± 1 y) and 40 older (74 ± 1 y) men, ingesting 20 g of casein 
protein resulted in mixed muscle fractional synthesis rate being 16% lower over 
the 4 - 6 h period  in the older group (Wall et al., 2015). Fractional synthesis rate 
(FSR) is the rate (%.h-1) that muscle is being synthesised. However, in contrast to 
these findings when a larger bolus of 15 g EAAs (~30 g P) was ingested, similar 
increases in mixed muscle FSR was observed in the older (~67 y) and younger (~34 
y) groups of men and women (Paddon-Jones et al., 2004). These findings indicate 
that while the capacity to stimulate MPS with protein ingestion is kept with aging, 
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the skeletal muscle is less sensitive and responsive to the ingestion of lower doses 
of amino acids (10 g or less of EAA)  (Dickinson et al., 2013). A larger dose may be 
needed to overcome the impaired MPS response and to synthesise muscle 
proteins equivalent to that in younger individuals. 
   Anabolic resistance to exercise in the fasted state 
Anabolic resistance to MPS following exercise in the fasted state draws on findings 
from resistance exercise (RE) interventions due to a lack of endurance exercise-
based studies. After an acute bout of resistance exercise, MPS, mTORC1 and its 
downstream effectors showed a reduced responsiveness in untrained elderly (67 
± 2 y) men and women (Fry et al., 2011). When an acute bout of RE was performed 
at intensities between 60 - 90% one repetition maximum, S6K1 and 4E-BP1 
phosphorylation were reduced in older men (70 ± 5 y) compared to the younger 
men (24 ± 6 y), along with MPS (Kumar et al., 2009). These studies lend support to 
a lower MPS response to exercise in the fasted state, at least with RE and in 
untrained male subjects. 
   Anabolic resistance to endurance exercise and protein feeding 
An impaired ability to increase MPS when protein was ingested in close proximity 
to a bout of endurance exercise was found in untrained older (67 ± 2 y) men, with 
MPS reduced by 40% in the older compared to younger men following 45 minutes 
of low intensity walking and amino acid infusion (Durham et al., 2010). Although 
the transferability of this study to trained masters endurance athletes is 
questionable, one well conducted study in male masters triathletes lends support 
for anabolic resistance to MPS when protein is ingested post endurance exercise 
(Doering, Jenkins, et al., 2016).  
This study involved three consecutive days of intense endurance training. 
Following exercise sessions, five masters triathletes (53 ± 2 y) and six young 
triathletes (27 ± 2 y) consumed 20 g of whey protein isolate immediately after each 
exercise bout along with a daily protein intake of 1.6 g.kg-1, provided as 4 doses of 
0.3 g.kg-1 per meal,  in line with sport nutrition recommendations (1.2 g.kg-1 per 
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day, 0.25 - 0.3 g.kg-1 per meal). Master triathletes had significantly (p=0.009) lower 
myofibrillar FSR compared to the younger triathletes.  
Not all studies, however, have observed anabolic resistance to MPS when protein 
is ingested post-exercise in older adults. When seven untrained older (67 ± 2 y) 
and seven younger (29 ± 3 y) male and female adults ingested a protein rich meal 
of beef containing 90 g of protein, the synergistic response to RE and protein 
ingestion on MPS was the same in both groups at 3 h and 5 h post-exercise 
(Symons, Sheffield-Moore, Mamerow, Wolfe, & Paddon-Jones, 2011). This could 
be attributed to the 90 g protein dose and suggests that a higher dose of protein 
ingested post-exercise may be needed to counteract the anabolic resistance to 
MPS in the aging athlete. This highlights the importance of determining a dose to 
near maximally stimulate MPS post-exercise in older female endurance athletes 
to optimise recovery and the adaptive response.  
Dose response of dietary protein to MPS at rest and after exercise 
In younger resistance trained adults it is has been established that ingesting a 20 
g dose of protein (~10 g EAA) near maximally stimulates the MPS anabolic 
response at rest (Witard et al., 2014), and after resistance exercise (Moore et al., 
2008; Witard et al., 2014). In comparison to young adults, dose response studies 
in middle age (59 ± 2 y) and older (71 ± 5 y) male adults show that doses higher 
than 20 g result in greater amino acid absorption and subsequent MPS rates at 
rest (Moore et al., 2015; Pennings et al., 2012) and post-exercise (Robinson et al., 
2012; Yang, Breen, et al., 2012; Yang, Churchward-Venne, et al., 2012). 
To maximally stimulate MPS at rest and achieve equivalent rates to those of 
younger individuals, the findings of six previous dose-response studies were 
combined and a breakpoint analysis conducted (Moore et al., 2015). Protein doses 
were reported relative to body weight, with 0.25 g.kg-1 body mass maximally 
stimulating MPS in younger (~22 y) and 0.4 g.kg-1 in older (~71 y) men. Support for 
higher protein intakes to near maximally stimulate MPS in older adults is also 
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evident from dose response studies when protein is ingested post-exercise 
(Churchward-Venne, Holwerda, Phillips, & van Loon, 2016).   
Three studies (Robinson et al., 2012; Yang, Breen, et al., 2012; Yang, Churchward-
Venne, et al., 2012) have investigated the dose response of MPS to protein 
ingestion at rest and post-exercise. A summary is provided in Table 1. These three 
studies, using different sources of protein (beef, whey or soy), were comparable 
in their study designs. Participants were healthy but untrained men, of middle (~59 
y) or older (~71 y) age. A similar unilateral knee extensor resistance exercise was 
used in all studies. Diet was controlled in the two days prior to the trial and until 
trial completion. The studies used the same amino acid tracer, and all measured 
myofibrillar FSR over a 240 minute time frame. When graded doses of beef 
containing 0, 12, 24 or 36 g of protein were ingested by 35 middle age men (59 ± 
2 y) after resistance exercise, only the 36 g of protein showed a significant increase 
in MPS, with  no significant difference found between 0, 12 or 24 g of protein in 
MPS (Robinson et al., 2012). The need for a greater protein dose to elevate MPS 
in older adults was also reported when graded intakes of whey isolate 0, 10, 20 or 
40 g doses were ingested (Yang, Breen, et al., 2012). A minimum dose of 20 g was 
needed to increase MPS above exercise alone, with 40 g elevating MPS 32% more 
than 20 g post-exercise (Yang, Breen, et al., 2012). When soy protein isolate was 
ingested at 0, 20 or 40 g, only the 40 g dose increased MPS above exercise alone 
(Yang, Churchward-Venne, et al., 2012). This study also compared equivalent 
graded doses of soy protein to whey protein, with soy showing a reduced ability 
to stimulate MPS at 20 and 40 g doses (Yang, Churchward-Venne, et al., 2012). 
Table 1 provides a summary of dose response studies of MPS to protein ingestion. 
The author of this thesis acknowledges the work done by previous authors 
(Churchward-Venne et al., 2016; Doering, Reaburn, et al., 2016) in producing 
tables to summarise dose response studies of MPS to protein ingestion. These 
tables were adapted for the purpose of this review to allow for ease of comparison 
between the different studies.  
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Table 1.  Dose response relationship between protein ingestion and muscle 
protein synthesis (FSR) post resistance exercise in older adults 
 










     At rest Post 
Exercise 
Yang, Breen, et al. (2012) 30 70 ± 4 WI 0, 10, 
20, 40 
20 40 
Yang, Churchward-Venne,  
et al. (2012) 
30 71 ± 5 SI 0, 20, 40 40 40 
Robinson, et al. (2013) 35 59 ± 2 Beef 0, 12, 
24, 36 
36 36 
WI whey isolate, SI soy isolate, FSR fractional synthesis rate. 
Table adapted from Churchward-Venne et al. (2016); Doering, Reaburn, et al. (2016). 
 
Taken together these studies indicate that middle age and older men require a 
significantly larger amount (36-40 g) of protein post-exercise than the 20 g in 
younger adults to near maximally stimulate MPS, and that protein source is also 
an important factor in the MPS response. 
Protein source 
Evidence from studies in primarily male adults confirms that whey protein 
supports greater stimulation of MPS than soy (Phillips, Tang, & Moore, 2009; Yang, 
Churchward-Venne, et al., 2012) or casein protein (Burd et al., 2012; Pennings et 
al., 2011; Phillips et al., 2009; Yang, Churchward-Venne, et al., 2012), despite all 
three being considered as high quality proteins containing all the EAA needed to 
stimulate MPS (Phillips et al., 2009).  
The greater MPS response with whey protein is attributed to its faster digestion 
and absorption kinetics and amino acid composition, specifically its higher leucine 
content (Phillips, 2016). Leucine is an EAA that directly activates the mTORC1 
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signalling pathway and initiates an increase in MPS (Phillips, 2016). In elderly men 
and women a reduced sensitivity of MPS to the anabolic effects of leucine has 
been demonstrated (Katsanos, Kobayashi, Sheffield-Moore, Aarsland, & Wolfe, 
2006; Yang, Breen, et al., 2012), with a higher leucine content (~3.0 g) required to 
trigger a rise in MPS to a level equivalent to that seen in younger individuals (~1.85 
g) (Devries et al., 2018; Katsanos et al., 2006). The capacity to near maximally 
stimulate MPS with ~40 g of protein is likely linked to the increased activation of 
leucine with this higher dose (Churchward-Venne et al., 2016). While protein dose 
and source are key factors in maximising MPS in older athletes, timing of intake 
may also modulate the MPS response. 
Protein timing 
Consuming protein in the immediate post-exercise recovery period is 
recommended for enhancing MPS and net protein balance for repair and 
remodelling of muscle fibres, and to promote recovery after endurance exercise 
(Moore, Camera, Areta, & Hawley, 2014). However, this period for protein 
ingestion may be more important to masters endurance athletes, as delaying 
protein ingestion by as little as two hours was found to attenuate accretion of 
muscle protein in older men after resistance training (Esmarck et al., 2001). The 
MPS response to protein dose, source and timing have been investigated primarily 
in older males, however, there is evidence to suggest sexual dimorphism in the 
MPS response (Smith & Mittendorfer, 2016; Smith Gordon et al., 2012). 
   The effects of protein and exercise on MPS in women 
The impact of protein and exercise on MPS in women has been less well studied, 
however, a reduced sensitivity to the anabolic stimuli of protein and its leucine 
content (Devries et al., 2018; Katsanos et al., 2006), and to exercise (Burd, Tang, 
Moore, & Phillips, 2009), has been reported in females. This reduced sensitivity 
compared to their male counterparts is suggested to be linked to the decline in 
female hormones, particularly oestrogen concentrations (Hansen, 2018; Smith & 
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Mittendorfer, 2016). Considering women around menopausal age (~48 y) and 
older are also potentially more susceptible to muscle damage, optimising protein 
dose, source and timing may be of even greater importance to maximise the MPS 
response post-exercise. 
Summary 
In summary, to near maximally stimulate and achieve similar rates of MPS as 
younger populations, the available evidence suggests that post resistance 
exercise, untrained middle-age and older (~59 y plus) males, need to ingest ~40 g 
of a rapidly digested protein with a high leucine content such as whey isolate. To 
date there is a lack of data available to make clear recommendations on the 
amount of ingested protein needed to maximally stimulate MPS after endurance 
exercise in older female athletes. However, considering the distinct aging effects 
on skeletal muscle of older females (~48 y and older) it would be reasonable to 
suggest this higher protein intake post-exercise would be advantageous to 
facilitate the optimal repair and remodelling of skeletal muscle, and enhance 
recovery in older female endurance runners after EIMD.  
Section 3 - Acute protein supplementation post EIMD to improve recovery  
The potential benefits of protein supplementation to reduce the negative effects 
of EIMD and improve recovery has been extensively researched in younger (<40 y) 
adults, with females underrepresented in these studies. To date, only one study 
has been conducted in male masters endurance athletes (Doering, Reaburn, 
Borges, Cox, & Jenkins, 2017). Evidence from studies in younger populations for 
positive effects of protein ingestion before, during and/or after a single or multiple 
exercise session is equivocal (Cockburn, 2010; Pasiakos, Lieberman, & McLellan, 
2014), and likely due to the differences in study designs and methodologies.  
To reduce this heterogeneity, the following section is limited to studies 
investigating the effects of acute ingestion (within a 2 h time frame post-exercise) 
of protein, or carbohydrate and protein (CHO-P) following a single bout of muscle-
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damaging exercise. Excluded further from this review of studies were those 
including antioxidants in addition to protein or CHO-P supplement post-exercise 
(Ives et al., 2017), exercise protocols that were likely to result in metabolic rather 
than mechanical muscle damage (Lunn et al., 2012; Saunders, Kane, & Kent Todd, 
2004), and the protein supplement provided in several boluses post-exercise over 
an extended period (Buckley et al., 2010). 
Six studies are reviewed, with five demonstrating an attenuation in one or more 
markers of EIMD when protein or CHO-P was supplemented post-exercise 
(Cockburn, Hayes, French, Stevenson, & St Clair Gibson, 2008; Etheridge, Philp, & 
Watt, 2008; Rankin, Landy, Stevenson, & Cockburn, 2018; Rankin, Stevenson, & 
Cockburn, 2015; Saunders, Luden, Dewitt, Gross, & Rios, 2018). One study 
reported no beneficial effects (Green, Corona, Doyle, & Ingalls, 2008). A summary 
of these studies can be found in Table 2.  
Markers used to asses muscle damage to determine the effectiveness of protein 
supplementation post-exercise varied between studies. All but one study 
(Saunders et al., 2018) measured blood creatine kinase (CK), muscle soreness, and 
muscle function tests of peak isometric torque (PIMT) and/or peak isokinetic 
torque (PIT).  
Of these indirect markers, muscle function (a measure of the capacity of a muscle 
to generate force) is regarded as the most reliable and valid for quantifying the 
extent of muscle damage, as it best reflects muscle myofibrillar status (Owens et 
al., 2018; Paulsen et al., 2012). Five studies included one or more markers of 
muscle function, with four reporting a beneficial effect of CHO-P supplementation 
on improving muscle force generating capacity over a recovery period of 24-72 h 
(Cockburn et al., 2008; Etheridge et al., 2008; Rankin et al., 2018; Rankin et al., 
2015). 
In addition, the above-mentioned studies also included measurements for CK and 
muscle soreness. CK levels increased post-exercise in these studies for all 
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treatment groups. In two studies CK levels were reduced with the protein 
supplement at either 48 h (Cockburn et al., 2008) or 72 h (Rankin et al., 2015) post-
exercise compared to 24 h post-exercise levels. Muscle soreness increased post-
exercise but was attenuated with the protein supplement compared to the 
isocaloric CHO supplements (Rankin et al., 2015). It should be recognised however 
that CK and muscle soreness do not accurately reflect the extent of muscle 
damage (Warren, Lowe, & Armstrong, 1999) and weakly correlate with each other 
(Paulsen et al., 2012). They are not regarded as being adequately valid to be used 
on their own, but provide complimentary or extra information to muscle function 
measurements (Owens et al., 2018). 
Beneficial effects of a CHO-P supplement compared to a near isocaloric CHO 
supplement following a marathon run were reported (Saunders et al., 2018). This 
study measured CK, and perceptual measures of muscle soreness, physical fatigue 
and mental energy. CHO-P attenuated muscle soreness and physical fatigue over 
72 h recovery period. However, no measures for muscle function were included 
and sample size was very small (4/group), and as such results should be considered 
with caution. 
Confounding variables were not always controlled for in these studies which 
makes accurate interpretation difficult for determining the effectiveness of the 
protein supplement. Supplement treatments used in individual studies were not 
all isocaloric, with one study comparing 40 g of EAA (100 g P) to a non-isocaloric 
placebo (Etheridge et al., 2008), while another had differing quantities of CHO in 
the treatment groups (Cockburn et al., 2008). Several studies did not control for 
diet before or during the trial/s. For example, no attempt for dietary control was 
reported in two studies (Green et al., 2008; Saunders et al., 2018), while Cockburn 
and colleagues only requested participants to keep normal dietary habits 
throughout the intervention (Cockburn et al., 2008). Only two studies took 
measures to control for diet, where participants kept food records for the 24 h 
prior and 72 h post-exercise. Diets were analysed for energy and macronutrient 
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content, with no significant difference between groups reported (Rankin et al., 
2018; Rankin et al., 2015). 
An absence of dietary standardisation may be one plausible reason for Green and 
colleagues who observed no beneficial effect from CHO-P supplementation as 
opposed to carbohydrate (Green et al., 2008). These reported results oppose 
another (Etheridge et al., 2008) given they used the same exercise protocol of a 
30 minute downhill running (DHR), muscle damage markers and measurement 
time points. While Etheridge and colleagues used a cross over design and had 
participants replicate their dietary intake for the 24 h before and 72 h post-
exercise for the two trials and did not allow the consumption of additional meals 
earlier than 3 h after supplement ingestion, Green and colleagues implemented 
no dietary control at all.  
Two recent studies are comparable in their design and methodology (Rankin et al., 
2018; Rankin et al., 2015). Both used a parallel group design, participants were 
team sport athletes of a similar age (~22 y), with female only participants in one 
study (Rankin et al., 2018), and separate groups of male and females in the other 
(Rankin et al., 2015). The supplement treatments were taken immediately post-
exercise and were identical. The CHO placebo was isocaloric to the CH0-P 
supplement (milk). The protein supplement provided 17 g of protein (~0.27 g.kg-1 
in females), which is near to the amount known to maximally stimulate MPS.  Diet 
was controlled for in the 24 h prior to testing and during the 72 h recovery period. 
Results for the females in both studies showed protein supplementation improved 
muscle function. Peak isokinetic torque showed a likely/very likely beneficial effect 
from baseline to 24, 48 and 72 h (Rankin et al., 2015), and a very likely beneficial 
effect for PIT at 72 h and CMJ at 72 h (Rankin et al., 2018). 
This review of literature suggests acute protein intake following a bout of muscle-
damaging exercise has the potential to promote recovery of muscle function and 
enhance recovery over a 24-72 h period. There is more conclusive evidence for its 
potential benefit when markers of muscle function are included, the nutritional 
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treatments are isocaloric, diet is controlled for, and protein is provided 
immediately post-exercise, in amounts known to near maximally stimulate MPS in 
younger adults.  
While these studies assessed muscle recovery over several days, the only study of 
masters athletes (Table 2) supports a positive effect of protein supplementation 
on recovery of muscle function over a short time frame of 8 h (Doering et al., 
2017). The aim of this crossover study was to establish if three repeated boluses 
of a higher protein intakes (0.6 g.kg-1) compared to lower intakes (0.3 g.kg-1) after 
muscle-damaging exercise could improve recovery in the same day. A 30 minute 
DHR was used to induce muscle damage in eight well trained male masters 
triathletes, followed by an 8 h recovery period. The higher intakes of whey isolate 
protein attenuated reductions in afternoon PIMT to a greater degree, with a 
moderate beneficial effect compared to the lower protein. While this reduction in 
PIMT did not result in a beneficial effect on the time trial performance it does 
support the need for larger amounts of high-quality protein in older athletes, due 
to the changes in PIMT.    
Comparison between the study in masters and those in younger athletes is 
problematic due to the difference in age between the two groups and study 
interventions i.e. several boluses of protein over the recovery period compared to 
protein ingestion in the immediate post-exercise period, and differences in the 
recovery time period under investigation. While these findings cannot be 
generalised to older female endurance athletes, they do lend support for protein 
supplementation post-exercise to potentially attenuate decrements in muscle 
function and improve recovery in older female endurance runners.  
Section 4 - Limitations and future research 
A clear gap in literature exists on the nutritional practises of older female 
endurance runners and it cannot be established at this stage if the practises of 
these athletes are contributing to the attenuated recovery. There is the need for 
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comprehensive and well conducted nutrition assessments to be carried out in this 
cohort. This information is needed to establish current practise, and to provide 
appropriate and practical recommendations to optimise recovery. 
Research to date to determine the amount of protein ingested to maximally 
stimulate MPS after exercise has been primarily conducted in older untrained male 
subjects using resistance training protocols. There is a lack of data available to 
make any clear recommendations for older female endurance athletes on the 
amount of protein needed to maximally stimulate skeletal MPS. Research in this 
area is warranted given the increasing number of female athletes competing in 
endurance events, and the importance of dietary protein to facilitate the repair 
and remodelling of skeletal muscle leading to training induced adaptations and 
ultimately performance improvements. 
The studies reviewed for the effects of acute protein ingestion following EIMD in 
younger athletes highlighted several limitations in study design and methodology 
which damaged the internal validity of the results. These included not controlling 
for confounding variables and not including a valid marker for quantifying muscle 
damage. To ensure the correct analysis of results and reporting of findings, future 
investigations would benefit from stricter rigour paid to study design and 
methodologies.  
Research is in its infancy investigating the potential beneficial effects of protein 
supplementation to improve recovery after EIMD in older athletes. The only study 
in older male endurance athletes, while reporting a potential benefit in recovery 
of muscle function within the same day, does not allow for any conclusive 
recommendations to be made for this age group of males or for older females. 
Given the negative impact slower recovery can have on endurance training, 
adaptations and performance, this is an area where extensive research is 
warranted in both males and females to determine the efficacy of a higher protein 
supplementation dose on both acute and chronic muscle recovery.  
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Section 5 - Conclusions 
Endurance running is known to induce muscle damage. While the magnitude of 
damage is similar between male masters and younger athletes, masters athletes 
appear to take longer to recover. A slower recovery impacts on the quality of 
training sessions, limits adaptations and ultimately performance. Identifying key 
factors for this delayed recovery and means by which they can be modified to 
improve recovery time is therefore of significance. 
The older female endurance runner is an understudied yet distinct population, 
whose slower recovery is due to the aging effects on muscle; specifically, that of 
reduced oestrogen concentrations, known to augment muscle damage and 
attenuate the repair process, and an anabolic resistance to muscle protein 
synthesis.  
Anabolic resistance with aging reduces the sensitivity of skeletal muscle to 
increase MPS in response to the stimuli of protein or exercise. This impairment 
can be compensated for by ingesting a higher dose of protein than what is 
currently recommended (~20 g). The available evidence suggests that ingesting 
~40 g of a quickly digested, high leucine-content protein such as whey, in the 
immediate post-exercise period can near maximally stimulate MPS in older 
untrained men after resistance exercise. 
To date there is a lack of data available to make clear recommendations on the 
amount of protein need to maximally stimulate MPS after endurance exercise in 
older female athletes. However, given that older women (~48 y plus) have been 
shown to have a reduced sensitivity to the anabolic stimuli of protein and its 
leucine content compared to their male counterparts, and an increased 
susceptibility to muscle damage, it would be reasonable to propose that ingesting 
~40 g of whey protein in the immediate post-exercise period would be beneficial 
for optimising the repair and remodelling of skeletal muscle and hence recovery 
in older female endurance runners following EIMD. 
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Studies to date investigating acute protein supplementation to reduce the 
negative effects of EIMD and improve recovery have been limited to younger 
populations. Findings from these interventions suggest acute protein 
supplementation to be potentially beneficial in attenuating decrements in muscle 
function and enhancing recovery over a 24-72 h period. Evidence was more 
conclusive when stricter rigour was paid to study design and methodology. The 
one study with male masters triathletes found that higher than recommended 
repeated boluses of whey protein post-exercise improved recovery of muscle 
function over an 8 h period, lending support to the importance of protein source 
and the need for a larger dose in masters athletes. 
The beneficial effects of protein supplementation on the recovery of muscle 
function   reported in studies in younger populations, specifically female athletes, 
and the one study in male masters athletes cannot be extrapolated to the older 
female endurance runner. While a higher dose of whey protein proved beneficial 
in attenuating decrements in muscle function in male masters triathletes, there is 
no evidence to date for the efficacy of a higher (~40 g) acute protein dose post 




Table 2.  Summary of studies reporting effects of acute protein or protein-carbohydrate supplementation post-exercise on markers 
of exercise induced muscle damage following an acute bout of exercise 
 
Reference Participants Study Design  Exercise Protocol 




















6 sets x 10 reps/ leg 
1.05°/s  
CK, Mb, muscle soreness, 
PIT knee extensors/quad 
Pre, 24, 48 h post 
Immediately, 2 h, 500 ml 
Placebo: water 
CHO 64g  
CM: CHO-P 118 g/33 g  
Milk: CHO-P 49 g/34 g 
CM= Milk  CM and Milk > CHO 
and PLA for leg PIT, TW 48 h  
CM = Milk CM and Milk < CHO 












30 min at 10% decline 
75% predicted HRmax 
CK, muscle soreness, IMST 
quads, PPO (cycle erg) 
Pre, 24,48 72 h post 
Immediately 1000 ml 
PLA flavoured water 
P 100g (40 g EAA) 
P > PLA for IMST quads and 












30 min intermittent run 
12% grade at 8 mph 
CK, muscle soreness, IMST 
quads 
Pre, immediately post, 24 
48, 72 h post 
0, 30 min, 60 min  
Placebo non caloric 
CHO  Hr 1: 1.2 g.kg Hr 2: 0.6 g.kg  
CHO- P Hr 1:  1.2 g.kg /0.3 g.kg 
              Hr 2:  0.6 g.kg/0.15 g.kg 
No beneficial effect 
IMST quads returned to base 




16 M (23.7 ± 3.4y) 
16 F (21.9 ± 2.1y) 
Team sport  
Parallel 4 groups (1 
female 1 male group 
for each supplement 
Eccentric contractions 
knee flexors 
6 sets x 10 reps, 60 and 
180°/s 
CK, muscle soreness,  
PIT knee flexion, CMJ, 20m 
sprint performance 
pre, 24, 47 and 72 h post 
Immediately post, 500 ml  
Isocaloric Energy 910 kJ 
CHO 53.6 g  
Milk: CHO-P-FAT 25.5 g/17 g/5 g  
Both genders: Milk < muscle 
soreness, CK,  
Females: Milk > CHO PIT 24, 48 
and 72 h, 20 m sprint 
performance 72 h 
 
CHO carbohydrate, CK creatine kinase, CM chocolate milk, CMJ counter movement jump, CRP C reactive protein, F female, IKST isokinetic strength, IMST isometric strength, LDH lactate 
dehydrogenase, M male, Mb myoglobin, PIMT peak isometric torque, PIT peak isokinetic torque,  PLA placebo, PPO peak power output P protein, TTP time trial performance, TTE time to 





Table 2.  Summary of studies reporting effects of acute protein or protein-carbohydrate supplementation post-exercise on markers of 
exercise induced muscle damage following an acute bout of exercise (cond’t) 
Rankin et 
al., (2018) 
18 F (21.6 ± 3.4y) 
Team sport 
athletes 
Parallel 2 groups Sprints 15 x 20 m max 
10 plyometric jumps 
CK, CRP, muscle soreness, 
CMJ, PIT knee flexion, 
sprint performance 
pre, 24, 47 and 72 h post 
Immediately post, 500 ml  
Isocaloric Energy 910 kJ 
CHO 53.6g  
Milk: CHO-P-FAT 25.5g/17g/5g 
Milk > CHO for muscle 






4 F, 4 M (18-26y) 
2 groups mix 
Novice runners 
Parallel double blind 
 
Marathon run (42km) CK, muscle soreness, 
physical fatigue, mental 
energy 
Pre, 24, 72 h post 
Food bags similar caloric value 
Immediately post-exercise 
CHO 111 g ± 31 g 
CHO-P 57 g ± 9 g/ 28 ± 9 g 
CHO-P < CHO for muscle 
soreness, physical fatigue and > 




8 M (52.1 ±2.1y) 
Trained triathletes 
Crossover double 




30 min at 10% decline 
70% VO2max 
 
TTP Mb, muscle soreness, 
fatigue, motivation, PIMT,  
Pre, immediately post 
(Mb, recovery 
perceptions) 8 h (all), 
Immediately post, 2 and 4 h  
High P: CHO-P 1 g.kg/0.6 g.kg 
Moderate P: CHO-P 1.3 g.kg/0.3 
g.kg 
WPI for both 
High P > Mod P for PIMT knee 
extensors at 8 h post 
High P > Mod P for perceptual 




CHO carbohydrate, CK creatine kinase, CM chocolate milk, CMJ counter movement jump, CRP C reactive protein, F female, IKST isokinetic strength, IMST isometric strength, LDH 
lactate dehydrogenase, M male, Mb myoglobin, PIMT peak isometric torque, PIT peak isokinetic torque,  PLA placebo, PPO peak power output P protein, TTP time trial 








Effects of a higher acute protein intake 
post muscle-damaging exercise on 






Masters athletes appear to take longer to recover after muscle-damaging exercise 
than their younger counterparts. The purpose of this study was to compare the 
effect of a higher (40 g) acute protein intake versus the recommended intake (20 
g) immediately following muscle-damaging exercise in older female endurance 
runners on the recovery of muscle function, perceived muscle soreness, and 
flexibility within a 24 hour (h) period. Six well trained female endurance runners, 
48 years of age and older (mean ± SD: age; 52 ± 5.6 y, body mass; 61.4 ± 6.2 kg) 
completed three trials separated by seven days, in a randomised Latin square, 
cross-over placebo-controlled study, with participants blinded to treatments. Prior 
to the first trial baseline measures for isometric maximal voluntary contraction of 
the knee extensors, peak countermovement jump height (CMJ), muscle soreness 
and hamstring flexibility were taken. These measures were retested at 3 h and 24 
h post run. Trials consisted of a morning (between 7 am and 10.30 am) 30 minute 
downhill run  (-10% grade, 80% age predicted HRmax) to induce eccentric muscle 
damage, followed by the consumption of a higher protein intake (P40) (protein-
carbohydrate 40 g-30 g, 1190 kJ), a recommended protein intake (P20) (protein-
carbohydrate 20 g-50 g, 1190 kJ) or a placebo (PLA) (carbohydrate 70 g, 1190 kJ). 
The P40 had a likely small beneficial effect compared to the PLA (ES = 0.24 ± 0.5) 
and P20 (ES = 0.25 ± 0.29) for improving maximum voluntary contraction from 
baseline to 24 h. The P40 had a likely small beneficial effect for improving 
countermovement jump height compared to P20 from baseline to 3 h (ES = 2.9 ± 
4.9) and to 24 h compared to the PLA (ES = 0.32 ± 0.39) and P20 (ES = 0.27 ± 0.19). 
P40 had an unclear effect on muscle soreness and flexibility. In conclusion the 
acute ingestion of 40 g of whey protein isolate, double the recommended, post-
exercise intake, improved recovery of muscle function within 24 h. This intake may 
be beneficial in enabling these athletes to better maintain the quality of training 
sessions, promoting training induced adaptations and improving performance, 





Endurance running has been shown to induce muscle damage, particularly the 
eccentric loading of downhill running (DHR) (Brisswalter & Nosaka, 2013). Masters 
(≥ 45 years) male endurance athletes display a similar magnitude of muscle 
damage as their younger counterparts after muscle-damaging exercise but appear 
to take longer to adapt to and recover from the muscle damage (Brisswalter & 
Nosaka, 2013; Easthope et al., 2010). A slower rate of recovery can negatively 
impact on the quality of subsequent bouts of training, limiting adaptations and 
ultimately performance (Barnett, 2006; Bishop et al., 2008; Fell & Williams, 2008).  
Identifying factors for this delayed recovery and means by which they can be 
modified to improve recovery time is therefore of utmost importance.  
One reason for attenuated recovery may be the age-associated impairment of 
protein synthesis in response to the anabolic stimuli of dietary protein/amino 
acids and exercise, termed ‘anabolic resistance’ (Cuthbertson et al., 2005; 
Dickinson et al., 2013). While it is well known that adequate dietary protein intake 
in the post-exercise period is vital for improving protein balance, and hence the 
repair and remodelling of skeletal muscle, research indicates that untrained older 
adults (Yang, Churchward-Venne, et al., 2012) and masters endurance athletes 
(Doering, Jenkins, et al., 2016) have a reduced sensitivity to the protein dose (20 
g) associated with maximal stimulation of post-exercise muscle protein synthesis 
(MPS) signalling in younger adults (~22 y) (Moore et al., 2008; Witard et al., 2014).  
This anabolic resistance to protein ingestion in older adults can be offset by 
ingesting a higher dose of protein; 36-40 g protein, post resistance exercise (RE), 
inducing a near maximal stimulation of MPS signalling in middle age and older 
untrained males (Robinson et al., 2012; Yang, Breen, et al., 2012; Yang, 
Churchward-Venne, et al., 2012). Post-exercise muscle anabolism may also be 
modulated by the source and timing of ingestion, with a quickly digested source 




in the immediate (0-1 h) post-exercise period (Esmarck et al., 2001; Moore et al., 
2014) maximising the MPS signalling response. These findings suggest that the 
acute ingestion of ~40 g of whey protein immediately following muscle-damaging 
exercise should facilitate the optimal repair and remodelling of skeletal muscle 
and enhance recovery time in male masters athletes.  
Studies to date investigating acute protein supplementation to reduce the 
negative effects of exercise induced muscle damage (EIMD) and improve recovery 
are limited to younger populations (Cockburn et al., 2008; Etheridge et al., 2008; 
Green et al., 2008; Rankin et al., 2018; Rankin et al., 2015; Saunders et al., 2018). 
Although these findings cannot be generalised to older populations, the results 
from five of the six studies provide evidence for a potential benefit for attenuating 
decrements in muscle function and enhancing recovery over 24-72 h. The one 
study in masters endurance athletes (male masters triathletes) reported that 
higher than recommended repeated boluses (3 feedings of 0.6 g.kg-1.bolus-1 at 2 h 
intervals, commencing immediately post-exercise) of whey protein isolate (WPI) 
post-exercise improved recovery of muscle function over an 8 h period (Doering 
et al., 2017). While this was not an acute supplementation protocol, and in male 
master triathletes, it lends support to the importance of protein source (whey) 
and the need for a larger dose in masters athletes than their younger counterparts.   
Currently, there is limited data to identify the effects of acute protein 
supplementation on recovery from daily bouts of training in older (≥48 y) female 
endurance runners, despite increasing participation in endurance running events 
in this population (Knechtle et al., 2012; Lepers & Stapley, 2016). Older female 
endurance runners are an understudied yet distinct population whose reduced 
recovery may be further influenced by the decline in oestrogen levels associated 
with the onset of menopause (mid to late 40s), specifically that of estradiol-17β 
(Hansen, 2018; Smith & Mittendorfer, 2016). Lower oestrogen levels have been 




2018; Katsanos et al., 2006), an augmentation in muscle damage and attenuation 
in the repair process (Enns & Tiidus, 2010).   
The primary aim of the current study was to compare the effect of a higher (40 g) 
acute protein intake versus a recommended intake for endurance athletes (20 g) 
immediately following muscle-damaging exercise on recovery of muscle function, 
perceived muscle soreness and flexibility within a 24 h recovery period in older 
female endurance runners. It was hypothesised that the higher acute protein 
intake post muscle-damaging exercise would improve recovery and reduce 
decrements in muscle function, flexibility and soreness within a 24 h recovery 
period in older (≥ 48 y) female endurance runners.  
Inappropriate recovery practises in this cohort may also contribute to the 
compromised recovery, however, to date no nutritional assessments have been 
conducted to support this. Therefore, the secondary aim of this study, was to 
assess the typical dietary practises of this cohort post training, specifically protein 
intake during the immediate post-exercise period, as compared to current sport 




Six well-trained, female endurance runners 48 y of age and older (52 ± 5.6 y) 
participated in the study. Runners were recruited through running groups, running 
events and by word of mouth from the Bay of Plenty Region, New Zealand. 
Participant characteristics can be viewed in Table 3. Exclusion criteria were age 
less than 48 y, training less than 5 h a week or for a race distance less than 10 
kilometres in competition, on hormone replacement therapy, cardiovascular or 
kidney diseases, diabetes or joint injuries of the lower body, and unable to 




Human Research Ethics Committee. All subjects provided voluntary written 
informed consent prior to participation in the study. The study took place from 
November 2018 to February 2019. 
Table 3.  Participant characteristics 
 
Characteristics Mean ± SD 
Age (y) 51.5 ± 5.6 
Height (cm) 167 ± 4.2 
Body mass (kg) 61.4 ± 6.2 
Body mass index  22 ± 1.9 
Years in endurance running 11.3 ± 9.5 
Training volume (h.week-1) 7.3 ± 4.3 
 
Study design 
Participants completed a familiarisation session, followed 6-8 days later by the 
first of three trials that were conducted exactly one week apart at the same time 
of day. The study was a Latin square, cross-over placebo-controlled design, with 
participants blinded to supplement treatments. Randomisation to supplement 
order was computer generated using publicly available software 
(http://www.randomization.com). Preliminary testing and trials took place in the 
laboratory at the University of Waikato Adams Centre for High Performance, 
Mount Maunganui, Tauranga, New Zealand. 
Preliminary testing 
Participants completed a physical activity readiness questionnaire (PAR-Q & You) 
and a training questionnaire. Anthropometric measurements for body mass (kg), 




(cm), measured to the nearest 0.1 cm (portable stadiometer: Seca, Germany) were 
taken.  Following this, instructions for filling in food records and training logs were 
given. A familiarisation session was then completed for tests to measure muscle 
recovery: an isometric squat for perceived muscle soreness, sit and reach test for 
hamstring flexibility, a countermovement squat jump (CMJ), and an isometric 
maximal voluntary contraction (MVC) of the knee extensors. A treadmill (Steelflex 
PT 10 Commercial Treadmill, UK) test to establish downhill running speed at 80% 
maximum heart rate (HRmax) was then conducted.  
Treadmill testing commenced with a 5-minute warm up at a self-selected pace on 
a level gradient. Following the warm up, the treadmill gradient was set at a 10% 
decline and subjects ran for 30 minutes at a target average heart rate (heart rate 
monitor: H10 Polar Electro, Finland) of 80% predicted HRmax. Heart rate max was 
calculated as:  HRmax = 208 – (0.7 x age) (Tanaka, Monahan, & Seals, 2001). This 
intensity corresponds to ~70% VO2max and is consistent with previous research that 
uses DHR to induce muscle damage (Braun & Dutto, 2003; Etheridge et al., 2008). 
Treadmill speed, heart rate and rate of perceived exertion (RPE) (Borg, 1982) were 
monitored continuously and recorded every 5 minutes with treadmill speed 
altered accordingly at these time points to maintain heart rate as close as possible 
to 80% HRmax  (heart rate was kept within ± 5 beats/minute of participants 80% 
HRmax) and a RPE between 12-14.  
Participants were provided with detailed verbal and written instructions along 
with templates for food recording. Participants were asked to record the date, 
time the meal was eaten, meal type (e.g. breakfast), detailed description of the 
food, including brand if applicable, cooking method, and portion size. Portions 
were estimated from either standard household measures, food packaging labels 
(volume or weight), and diagrams provided to participants. Recipes or amounts 
for combination foods or mixed dishes were also recorded. Participants were 




their normal dietary intakes. Participants were asked to maintain their normal 
eating habits throughout the recording periods. 
Instructions for filling in the training log along with a template was provided to 
participants. Participants recorded the date, start and finish time of training, 
description of training and intensity as either light (little effort, can carry on full 
conversation), moderate (moderate effort, noticeably accelerates the heart rate), 
vigorous (large amount of effort, rapid breathing, substantial increase in heart 
rate). 
The familiarisation session served to acclimate subjects to exercise protocols with 
the goal of minimising any possible order effects in the subsequent trials and 
systematic errors, specifically from the repeated bout effect (RBE) (Hyldahl et al., 
2017) on muscle damage, and the learning effect (Green, Parro, & Gabriel, 2014; 
Pekünlü & Özsu, 2014) from performing MVC of knee extensors and CMJ.  
Trial overview 
A schematic overview of the experimental trials can be found in Figure 2. 
Participants reported to the lab between 7 a.m. and 10.30 a.m. for each trial. 
Baseline measures for the dependent variables were taken prior to the DHR in the 
following order: perceived muscle soreness of the lower body, hamstring 
flexibility, peak isometric strength of the knee extensors and maximum 
countermovement jump height. Following baseline testing participants completed 
a 5-minute warm up at a self-selected pace on a level treadmill before completing 
a 30 minute DHR protocol to induce muscle damage. Immediately post run (0 h) 
the same measures for dependant variables were taken, followed by participants 
consuming one of three experimental beverages. Only water could be consumed 
in the 3 h period between supplement ingestion and the 3 h post-test for 
dependent variables. Measures for dependant variables were taken again at 3 h 




baseline testing and at 3 h and 24 h post run testing for dependant variables to 
avoid injuries and prepare the muscles for testing. 
Participants refrained from exercise training, caffeine, non-steroid anti-
inflammatory drugs (NSAID) and alcohol for 24 h before trials. For the 24 h period 
post DHR, participants were asked to avoid training, NSAID, supplements (protein, 
vitamins or minerals) and the use of other recovery modes (e.g. compression 
garments, massage).   
                                                        DHR 
  
                                                  Pre         O h             3 h                                                24 h 
 
Supplement 
Measurement of  
dependent variables 
 
Dietary                              48h pre                                                                                              24hpost   
standardisation     
Figure 2.  Schematic of testing protocol illustrating the time point when the 
supplement was consumed and when the measures for dependent variables 
were taken. 
 
Downhill run protocol 
Participants completed a 5-minute warm up at self-selected pace, on a level 
gradient followed by a 30 minute DHR at 10% decline, at an intensity 
corresponding to as close as possible to 80% HRmax to induce muscle damage. 
Downhill running speeds at 80% HRmax established in preliminary testing were 
used in trial one, however if required adjustments to running speed were made 




across trials, the running speeds and corresponding times in trial one was 
replicated for trial two and three. Heart rate, RPE, and running speed were 
monitored and recorded every 5 minutes in all trials. 
Dietary and exercise standardisation 
Participants completed a dietary food record for 48 h prior to each trial and 
throughout the trial period until the 24 h post-test. For dietary standardisation 
(Jeacocke & Burke, 2010) across trials, participants were asked to replicate these 
diets for the subsequent two trials. Participants noted any changes on their food 
record they made during these periods. All records were checked by the 
researcher before Trial 2 and 3 for compliance and to ensure any dietary changes 
that had been made were of an energy and macronutrient content similar to the 
original food record. Food records were analysed for energy and macronutrient 
content using dietary analysis software FoodWorks 9 (Xyris Software, Brisbane, 
Australia).  
For exercise standardisation a training log was kept for a week before the first trial 
and participants were asked to keep to a similar training plan (i.e. no new blocks 
of training started) during the entire study period.  
Supplementation protocol 
Immediately following measurements for dependent variables post run (0 h), 
participants consumed one of three recovery beverages.  Energy and 
macronutrient composition of the recovery beverages are shown in Table 4. All 
beverages were isovolumetric (250 ml), isocaloric (1190 kJ) and were matched for 
taste, colour and consistency. Beverages were consumed within 3 minutes of 
being provided. All beverages consisted of commercially available ingredients that 
were easy to prepare as a smoothie-based drink.  
Carbohydrate (CHO) placebo CHO 70 g (PLA). Supplement composition: 25 g 




gum (0.25 g) was used to thicken the beverage and 1.2 ml vanilla essence used for 
flavouring.   
Protein-Carbohydrate 20 g-50 g (P20). Supplement composition: 22.8 g of WPI 
vanilla flavour protein powder containing 2.4 g leucine (Balance), 10 g of glucose 
powder (King), 10 g Nesquik banana flavour (Nestle) and 150 g of banana. Twenty 
grams of protein is in line with current recommendations to support post-exercise 
recovery (Beelen, Burke, Gibala, & Van Loon, 2010).           
Protein-Carbohydrate 40 g-30 g (P40).  Supplement composition was 45.6 g of WPI 
vanilla flavour protein powder containing 4.8 g leucine (Balance), 10 g Nesquik, 
banana flavour (Nestle), 92 g banana. Forty grams of protein is the suggested 
amount to near maximally stimulate MPS in older adults after resistance training 
(Yang, Breen, et al., 2012) and 30 grams of CHO is sufficient to maximise 
hyperinsulinemia and to maximise the inhibition of protein breakdown (Glynn et 
al., 2010). 
Table 4.  Nutritional content of supplements 
 
Supplement Energy (kJ) CHO (g) Protein (g) Leucine (g) Fat (g) 
Placebo  1190 70 0 0 0 
Protein 20 g 1190 50 20 2.4 Trace 
Protein 40 g 1190 30 40 4.8 Trace 
 
To determine blinding of participants to the supplements, they were given a 
questionnaire after the final trial to determine which supplement condition they 
perceived to have been assigned to for each trial and to assess how well-matched 





Muscle recovery testing procedures 
   Knee Extensor Isometric Strength  
Peak isometric strength of the knee extensors was assessed using a digital force 
gauge (MARK-10 Series 3 Force Gauge, USA). Participants sat on a custom-made 
bench to which the strain gauge was attached. The participants’ dominant leg was 
firmly strapped to the bench across the mid-thigh. Immediately above the malleoli 
on the dominant leg an ankle cuff was attached, with a chain connecting the cuff 
to the strain gauge. Maximal voluntary contraction of the knee extensors was 
performed at a knee joint angle of 90°. The angle was assessed before each 
repetition with a goniometer, at the lateral condyle of the femur. Two submaximal 
contractions were performed prior to the first of the three MVC tests. MVC were 
performed for 3 seconds, with 60 seconds rest between tests. A 3 second 
countdown preceded tests and strong verbal encouragement was given to the 
participants during each attempt. MVC were recorded (Newtons) with the 
maximum MVC value used for data analysis.  
  Countermovement Jump Height 
Counter movement jump height (measured by flight time) was determined using 
MyJump 2 app on an iPhone 6s (Apple Inc, USA), a reliable and valid tool for 
evaluating vertical jump performance (Driller, Tavares, McMaster, & O’donnell, 
2017; Stanton, Wintour, & Kean, 2017). To record the jump, the researcher lay 
prone on the ground facing the participant (frontal plane) at 1.5 m from the 
participant and zoomed in on the participant’s feet. Take off phase was the first 
frame in which both feet were off the ground and landing phase was the first 
frame in which one foot was touching the ground (Driller et al., 2017). Participants 
stood on the floor with their feet shoulder width apart, hands on hips, and 
descended rapidly to approximately 90° knee angle and then in one continuous 
movement jumped vertically as high as possible with legs fully extended and hands 




before the first of 3 maximal test jumps. Test jumps were separated by 90 seconds 
with the highest jump used for analysis. Verbal encouragement was given before 
jumps. 
  Muscle Soreness 
Muscle soreness of the lower limbs was evaluated using a visual analogue scale 
(VAS) (Hawker, Mian, Kendzerska, & French, 2011). The VAS was a 100 mm long 
horizontal line with anchor points on either end stating no muscle soreness on the 
far left, to muscle soreness as bad as it could be on the far right. Subjects 
performed a 5 second isometric squat with their ankles, knees and hips at 90°, or 
as close to 90° as possible. Participants then placed a vertical line at the point on 
the scale corresponding to their perceived level of soreness. The distance (mm) 
between the no muscle soreness anchor and the participant’s mark was measured 
and recorded for analysis. 
  Hamstring flexibility 
Hamstring flexibility was measured with a YMCA sit and reach test using a 
standardised testing procedure (Pescatello, 2014, p. 106). In brief, participants 
slowly reached forward as far as possible with the fingertips of both hands 
overlapped and in contact with the measuring tape and held this position for 2 
seconds. Each participant performed the test three times and the highest value 
achieved was used for analysis. 
Dietary intake: Assessment of actual vs guidelines 
In addition to conducting the main study, the study also assessed post-exercise 
protein intake in the immediate (0-1 h) recovery period for two typical training 
days. Food records and training logs were kept in the same manner as previously 
described. Dietary software FoodWorks 9 (Xyris Software, Brisbane Australia) was 




errors, the same researcher who was familiar with the dietary analysis software 
entered all records.  
Statistical analysis 
Simple descriptive statistics are expressed as means ± between subject standard 
deviation (SD). Baseline values were established as the first MVC, CMJ, and 
hamstring flexibility score achieved at the first trial, and used in subsequent data 
analysis. Mean effects and 90% confidence limits (CL) of protein dose (P20 vs P40) 
and placebo were estimated using a published spreadsheet (Hopkins, 2006). Data 
for CMJ, MVC and sit and reach measurements were log-transformed to reduce 
bias from non-uniformity of error, and back-transformed to express changes in 
means as percent. Soreness values were not log-transformed because of interval 
scaling (Nevill & Lane, 2007). Supplement effects were analysed by comparing 
changes in MVC, CMJ, muscle soreness and hamstring flexibility across trials (PLA 
vs. P20 vs. P40). 
Effects were expressed as raw units, percentage changes and standardised effects. 
The magnitude of effect size (ES) is expressed using Cohen’s thresholds of <0.2 
(trivial), 0.2-0.6 (small), 0.6-1.2 (moderate), 1.2-2.0 (large), 2.0-4.0 (very large) 
>4.0 (extremely large) (Hopkins, Marshall, Batterham, & Hanin, 2009). The 
smallest worthwhile effect was assumed to be 1% (Hopkins, 2017). 
Post-exercise protein intakes were assessed for the proportion (%) and number of 
total training sessions  undertaken by participants in which protein intake either 
met suggested intakes for older athletes (Doering, Reaburn, et al., 2016), met 
current sport nutrition guidelines (Moore, 2015; Thomas, Erdman, Burke, & 
Mackillop, 2016), did not meet current sport nutrition guidelines, or there was no 







Of the 19 participants assessed for eligibility in the study, 13 were excluded, two 
for not meeting the inclusion criteria and 11 declined to participate for other 
reasons. Of the 6 participants recruited, all 6 completed all three trials, and all data 
from the 6 participants was analysed. 
Maximal Voluntary Contraction 
Mean baseline MVC was 334.7 ± 55.4 N. MVC at 3 h post DHR was 296.3 ± 57.5 N 
(PLA), 297.7 ± 49.2 N (P20), and 303.0 ± 45.3 N (P40). The difference between P20 
and PLA was 0.9 ± 10.6%, P40 and PLA 2.9 ± 13.4% and P40 and P20 2.0 ± 13.4%. 
There are unclear outcomes for any beneficial effect for P20 and PLA, P40 and PLA, 
and P40 and P20.  
Mean MVC at 24 h post was 305.0 ± 65.0 N (PLA), 301.7 ± 49.9 N (P20) and 318.2 
± 41.4 N (P40). The difference between P20 and PLA was 0.2 ± 8.4%, P40 and PLA 
was 5.8 ± 12.5%, and P40 and P20 was 5.9 ± 7.1%. There is a likely small beneficial 






Figure 3.  Maximal voluntary contraction performance (% change from baseline) 
post downhill run in the placebo (n = 6), protein 20 g (P20) (n = 6), and protein 40 
g (P40) (n = 6) groups.    
 
Countermovement Jump 
Mean baseline CMJ was 17.8 ± 1.4 cm. Mean values for CMJ at 3 h post was 18.4 
± 2.3 cm placebo (PLA), 17.9 ± 2.2 cm protein 20 g (P20) and 18.4 ± 1.5 protein 40 
g (P40). The difference between P20 and PLA was -2.9 ± 4.5%, P40 and PLA, 0.0 ± 
5.2%, and P40 and P20, 2.8 ± 4.2%. There was a likely small beneficial effect for 
PLA and P40 relative to P20 (ES = PLA: 0.24 ± 0.36, P40: 0.23 ± 0.34). 
Mean values for CMJ at 24 h post was 17.5 ± 1.7 cm, 17.5 ± 1.1 cm, 18 ± 1.3 cm 
observed for PLA, P20 and P40 respectively. The difference between P20 and PLA 
was 0.1 ± 3.3%, P40 and PLA was 3 ± 3.7% and P40 and P20 2.9 ± 1.9%. There was 
a likely small beneficial effect for P40 relative to PLA and P20, (ES = 0.32 ± 0.39 and 

























Figure 4.  Countermovement jump performance (% change from baseline) post 
downhill running in the placebo (n = 6), protein 20 g (P20) (n = 6) and protein 40 
g (P40) (n = 6) groups. 
 
Hamstring Flexibility: (500 mm at heels for sit and reach test) 
Mean baseline hamstring flexibility was 360.5 ± 77.3 mm. Hamstring flexibility at 
3 h post was 407.7 ± 40 mm (PLA), 408.5 ± 63 mm (P20), and 419.7 ± 58.1 mm 
(P40). The difference between P20 and PLA was -0.4 ± 8.4%, P40 and PLA 2.5 ± 
6.4% and P40 and P20 2.9 ± 3.8%. There was a likely trivial beneficial effect for P40 
relative to P20 (ES = 0.14 ± 0.18). 
Hamstring flexibility at 24 h post was 389.0 ± 51.6 mm (PLA), 388.7 ± 46.7 mm 
(P20), and 406.7 ± 63.7 mm (P40). The difference between P20 and PLA was 0.1 ± 
8.1%, P40 and PLA 4.3 ± 15.3% and P40 and P20 4.2 ± 13.7%. There were unclear 
outcomes for any beneficial effect for P20 and PLA, P40 and PLA, and P40 and P20. 
Muscle Soreness  
Mean baseline muscle soreness was 10.3 mm (VAS 0-100 mm). Muscle soreness 
at 3 h post was 17.8 ± 24.8 mm (PLA), 19.2 ± 19.4 mm (P20), and 23.0 ± 19.1 mm 
























15.2% and P40 and P20 3.8 ± 14.4%. There were unclear outcomes for any 
beneficial effect between P20 and PLA, P40 and PLA, and P40 and P20.  
Muscle soreness at 24 h post was 18.3 ± 22.1 mm (PLA), 21.1 ± 22.5 mm (P20) and 
14.7 ± 19.6 mm (P40). The difference between P20 and PLA was 2.8 ± 22.6%, P40 
and PLA -3.7 ± 8.2% and P40 and P20 -6.4 ± 20.0%. There were unclear outcomes 
for any beneficial effect for P20 and PLA, P40 and PLA, and P40 and P20.  
For analysis it was decided to not include the immediate 0 time point 
measurements for CMJ, MVC, hamstring flexibility and muscle soreness. 
Metabolic fatigue immediately post-exercise is likely to contribute to reductions 
in MVC and muscle soreness (Warren et al., 1999). Post activation potentiation 
and increased intramuscular temperature may influence CMJ height (Hughes, 
Massiah, & Clarke, 2016), and an increase in muscle temperature and eccentric 
muscle actions influence hamstring flexibility (O'Sullivan, McAuliffe, & DeBurca, 
2012). These factors would have made a positive change and not negative change 












Table 5.  Summary of the effect of the supplements on maximal voluntary 
contraction, countermovement jump height, and hamstring flexibility 3 hours 
and 24 hours following the downhill run 
      
  Time frame 
  3 hours 24 hours 
Exercise Comparison Mean 
effect (%) 





± 90% CI 
Qualitative 
outcomea MVC P20-PLA  0.9 ± 10.6 n lear -0.2 ± 8.4 n lear 
 P40-PLA  2.9 ± 13.4 unclear  5.8 ± 12.5 likelyb 
 P40-P20  2.0 ± 13.4 unclear  5.9 ± 7.1 likelyb 
      
CMJ P20-PLA -2.9 ± 4.5 unlikely  0.1 ± 3.3 unclear 
 P40-PLA      0 ± 5.2 unclear  3.0 ± 3.7 likelyb 
 P40-P20   2.8 ± 4.2 likelyb  2.9 ± 4.9 likelyb 
      
HSF P20-PLA -0.4 ± 8.4 unclear  0.1 ± 8.1 unclear 
 P40-PLA  2.5 ± 3.8 unclear  4.3 ± 15.3 unclear 
 P40-P20  2.9 ± 3.8 likelyb  4.2 ± 13.7 unclear 
      
Note. Results for log-transformed data only CI = confidence interval; CMJ = countermovement 
jump; HSF= hamstring flexibility. 
a With reference to a smallest worthwhile change of 1.0%.  
b Likely beneficial. 
 
Dietary Standardisation 
According to the food logs kept by participants compliance was high for the 
replication of diets for the 48 h pre and 24 h post downhill run in all three trials. 
Energy and macronutrient intakes over the 72 h (48 h prior to trials and 24 h post 
DHR) were energy intake: 9796 ± 1904 kJ, 160 ± 32 kJ.kg-1, CHO: 225 ± 98 g, 3.7 ± 
1.8 g.kg-1, PRO: 105 ± 20 g, 1.7 ± 0.3 g.kg-1, Fat: 100 ± 44 g, 1.6 ± 0.7 g.kg-1.  
Protein intakes for all participants were over 1.2 g.kg-1 body mass for the 48 h pre 






Blinding of Subjects to Treatments 
Testing for blinding of participants to the supplement treatments can be viewed 
in Table 6. For the 18 supplement trials participants either incorrectly identified 
the supplement or did not know what it was 67% of the time, and correctly 
identified the supplement 33% of the time. Mean scores for how well the different 
supplements were matched for flavour, texture, colour and palatability were 3.9, 
4.2, 4.8, 4.7 out of five with five being no difference between treatments. 
Table 6.  Participant blinding to the supplement treatments (n = 18) 
 




Did not know (n) 
Placebo 2 2 2 
Protein 20 g 2 2 2 
Protein 40 g 2 1 3 
Total 6 5 7 
 
Secondary Study Aim: Protein Intake Immediately After Training 
Dietary practises of this cohort post training, specifically protein intake during the 
immediate (0-1 h) post-exercise period are shown in Figure 5. Of the 13 training 
sessions analysed 3 sessions had no protein intake in the immediate post-exercise 
period, 6 sessions had an intake below the recommended 20 g, and 4 sessions had 
an intake of 20 g or more, with 1 of these 4 sessions having an intake over 40 g. 





Figure 5.  Proportion of total training sessions (n = 13) where protein intake during 
the first hour of recovery was reported as no intake, inadequate amounts to meet 
sport nutrition guidelines, adequate amount to meet sport nutrition guidelines, or 










































This study is the first to investigate the effects of double the recommended protein 
intake, taken acutely post muscle-damaging exercise, on 24 h recovery in older 
female endurance runners. 
The primary findings of this study indicate that an acute dose of 40 g of WPI 
following a downhill run can improve/accelerate recovery of muscle function in 
older female endurance runners. The 40 g dose showed a likely small beneficial 
effect for attenuating decreases in MVC and improving CMJ height performance 
compared to 20 g of WPI or an isocaloric placebo at 24 h post-exercise, and a likely 
small beneficial effect for improving CMJ height at 3 h compared to 20 g of WPI. 
The observed benefits of 40 g of WPI are proposed to be from the larger dose of 
protein facilitating greater repair and remodelling of the myofibrillar fibres, and 
hence a more rapid improvement in the recovery of muscle function.  
The change in muscle protein metabolism with aging is suggested to be the 
underlying reason for the larger dose of protein improving muscle function in this 
study. There is strong evidence that in both older men and women, there is a 
reduced sensitivity with aging to the anabolic stimuli of protein ingestion 
(Cuthbertson et al., 2005; Dickinson et al., 2013). Research has shown that male 
master endurance athletes (Doering, Jenkins, et al., 2016) have significantly lower 
(p = 0.009) myofibrillar fractional synthesis rates post-exercise compared to their 
younger counterparts, to the 20 g dose known to maximally stimulate MPS in 
younger athletes (Moore et al., 2008; Witard et al., 2014). Furthermore, in middle 
age and older men a dose of ~36-40 g of protein is needed to near maximally 
stimulate MPS following RE (Robinson et al., 2012; Yang, Breen, et al., 2012; Yang, 
Churchward-Venne, et al., 2012).  To date however, there is a lack of research to 
make clear recommendations on the amount of protein needed to maximally 
stimulate MPS in older female endurance runners. Muscle protein synthesis rates 




and its leucine content, associated with the decline in oestrogen levels at the onset 
of menopause (mid to late 40s), in addition lower oestrogen levels are known to 
augment muscle damage and attenuate the repair process (Devries et al., 2018; 
Hansen, 2018; Katsanos et al., 2006). Although not directly measured, it would 
therefore be reasonable to suggest that the results of this study are from 40 g of 
protein being able to enhance the MPS response compared to 20 g, and hence 
facilitate a greater repair and remodelling of the myofibrillar fibres, and a more 
rapid improvement in the recovery of muscle function in this cohort.  
While studies of acute protein supplementation post-exercise in younger 
populations cannot be directly compared to the results of this study due to 
differences in age, protein metabolism, and methodologies, most lend support for 
acute protein supplementation to be beneficial in improving recovery of muscle 
function (Cockburn et al., 2008; Etheridge et al., 2008; Rankin et al., 2018; Rankin 
et al., 2015; Saunders et al., 2018). Furthermore, two of these studies demonstrate 
that when age specific protein doses known to maximally stimulate MPS are 
ingested, recovery of muscle function is improved (Rankin et al., 2018; Rankin et 
al., 2015). In both of these studies, peak isokinetic torque showed a very likely 
beneficial effect from baseline at 72 h when 17 g (~0.27 g.kg-1) was ingested by 
female team sport athletes. The only study in male masters athletes showed that 
repeated boluses of WPI (0.6 g.kg-1), improved recovery of muscle function in 
comparison to a lower dose (0.3 g.kg-1) (Doering et al., 2017), supporting the 
findings of the current study for a higher dose of whey protein isolate in improving 
muscle function.   
The unclear benefits of P20 compared to the placebo in any of the tests for 
measuring recovery in the current study may potentially be due to the leucine 
content (2.4 g) in this protein dose not being enough to activate the mammalian 
target of rapamycin complex 1 (mTORC1) pathway. Research suggests that ~3 g of 




level equivalent to that seen in younger individuals (Devries et al., 2018; Katsanos 
et al., 2006). 
Isometric MVC was reduced with all treatments at 3 h and 24 h from baseline 
measurements, indicating that the DHR protocol was effective in inducing a 
muscle damage response. Though not a direct marker of muscle damage, MVC is 
a functional measure and considered to be the most reliable and valid for 
quantifying the extent of muscle damage (Warren et al., 1999). The loss in muscle 
function at 24 h (9.6%) was of a smaller magnitude than in several studies in 
younger female population at this time point (Green et al., 2008; Rankin et al., 
2018; Rankin et al., 2015). This is likely due to differences in the training status of 
participants, exercise protocol used to induce muscle damage, and participants in 
this study unlikely to have benefited from the repeated bout effect. All were well 
trained endurance runners who regularly included DHR in their weekly training 
program.  
Although it is known that multi-joint performance is better maintained after EIMD 
than single joint (Douglas et al., 2017), the increases in CMJ height above baseline 
measures at 3 h for all supplements and at 24 h for P40 was an unexpected 
outcome of this study. One possible mechanism for this improved performance, is 
that the optimal length of tension development in the muscle was shifted to a 
longer muscle length following the DHR (Brughelli & Cronin, 2007). This adaptation 
potentially changed the mechanical properties of the muscle, increasing leg 
stiffness and enhancing the stretch shorten cycle of the CMJ, and hence improving 
performance (Brughelli & Cronin, 2007; Elmer, Hahn, McAllister, Leong, & Martin, 
2012). It is proposed that this enhancement in the stretch shorten cycle 
outweighed muscle damage at 3 h while at 24 h this acute adaptation was 
diminished, with P40 showing a beneficial effect over P20 and the placebo due to 
the improved repair and remodelling of muscle fibres from this higher dose. This 
adaptive response to eccentric exercise has important implications for these 




principal chronic eccentric loading would lead to sustained increases in leg 
stiffness, and as such improved performance. Future research in this area is 
warranted given that with aging endurance running performance is known to 
decrease (Lepers & Stapley, 2016). 
Studies of acute protein supplementation in younger populations, where CMJ was 
measured in females (Rankin et al., 2018; Rankin et al., 2015), do not support these 
findings for improved CMJ over baseline measures. These conflicting results may 
be from a difference in the muscular response to eccentric exercise with aging 
(O'Sullivan et al., 2012), different training programs of team sport athletes 
compared to older female endurance runners influencing CMJ performance after 
muscle-damaging exercise, and the time points for measuring CMJ performance 
(acute time frame vs. days).  
Reasons for the likely beneficial effect of placebo and P40 increasing CMJ above 
P20 at 3 h post recovery are not clear. It is possible the higher protein and 
carbohydrate facilitated a more rapid re-uptake of carbohydrate into the muscle, 
while the P20 resulted in a low glycogen content in the muscle, impairing the 
ability to release Ca2+ and reducing muscle power generation (Gejl et al., 2014), 
hence the lower jump height.  However, this remains speculative and warrants 
further investigation with a larger sample size. 
The sit and reach test showed no clear benefits for a higher protein intake nor did 
it show a reduction in flexibility of the hamstrings from baseline measures. These 
findings are likely from this single test not relating to the flexibility of the knee 
extensor muscles that absorb the most force when running downhill, which the 
most damage is inflicted upon (Douglas et al., 2017), and/or the proposed 
increased lower limb flexibility from eccentric training (O'Sullivan et al., 2012). This 
stresses the importance of considering the battery of tests that will most 
accurately reflect the recovery of those muscles damaged in the eccentric exercise 




test (Warren et al., 1999) to include for measuring recovery from exercise induced 
muscle damage. 
Muscle soreness increased with all supplements following the downhill run which 
agrees with acute protein supplementations in younger adults (Cockburn et al., 
2008; Rankin et al., 2018; Rankin et al., 2015; Saunders et al., 2018). At 24 h post-
exercise muscle soreness was still increasing with P20 and the PLA, while P40 
showed an attenuation, although there was no clear beneficial effect. This 
disparity between the benefit of P40 at 24 h improving muscle function and no 
clear benefit for muscle soreness is likely related to muscle soreness being a 
subjective measurement, and/or any clear benefit for protein supplementation for 
attenuating muscle soreness is seen at a later time point in the recovery. In 
younger athletes (team sport and endurance runners), a very likely beneficial 
effect for protein supplementation for attenuating muscle soreness was seen at 
72 h post-exercise, with no clear benefit seen at 24 h post EIMD (Rankin et al., 
2015; Saunders et al., 2018).  Future research should determine if a similar effect 
is seen after supplementing with 40 g of protein in older female endurance 
runners at later time points post-exercise. 
A limitation of this study was it did not measure oestrogen levels or strictly control 
for them. The decline in oestrogen associated with the onset of menopause (mid 
to late 40s), specifically that of estradiol-17β is linked to a reduced sensitivity to 
protein (Devries et al., 2018), an augmentation in muscle damage and attenuation 
in the repair process (Enns & Tiidus, 2010). While all participants were of an age 
where oestrogen levels generally decline, levels would have differed due to 
differences in participants menopausal status; 3 participants being post-
menopausal, 2 in the menopausal transition and 1 pre-menopausal. With the small 
sample size of this study and varying estrogen levels, it cannot be determined how 




While diet was not strictly controlled, there was high compliance by participants 
in replicating their diets for the 48 h prior to the downhill run and for the 24 h 
post. However, as dietary intake during the trial period may influence the trial 
intervention and performance measures, future studies could look to standardise 
diets not just within subjects but also between subjects by providing food in 
amounts scaled to body mass. 
Strengths of this study which allowed for a more accurate interpretation for 
determining the effectiveness of the supplements include ensuring that all 
supplements were isocaloric, and participants being effectively blinded to the 
supplement treatments, which is important given the performance testing 
involved in this study and the potential placebo effect.  
The secondary aim of this study was to assess the typical immediate post-exercise 
protein intake in these athletes after two training days. 
Post-exercise protein intake did not meet current sport nutrition guidelines for 
athletes after nearly 70% of the training sessions. It is recommended that 
endurance athletes ingest 20 g (approximately 0.25-0.3 g.kg-1 body mass) of a 
rapidly digested high leucine content protein, such as whey, in the immediate 
post-exercise recovery period to maximise MPS for the repair and remodelling of 
skeletal muscle and support a faster recovery following endurance exercise 
(Moore, 2015; Thomas et al., 2016).  
These guidelines do not differentiate between younger and masters athletes and 
this amount of protein does not represent the growing evidence for an increased 
requirement with aging (Robinson et al., 2012; Yang, Breen, et al., 2012). Doering 
and colleagues suggest that endurance athletes should consume a dose of 35-40 
g (~0.4 g.kg-1) of protein after muscle-damaging exercise to facilitate muscle repair 
and remodelling (Doering, Reaburn, et al., 2016). The findings of the current study 
support these higher protein recommendations, however after only one of the 13 




These results suggest that poor dietary protein intake in the immediate post-
exercise recovery period may be compromising post-exercise MPS rates for the 
repair and remodelling of muscle fibres, and potentially contributing to a slower 
recovery in this cohort.  Further research into the nutritional recovery practises in 
this immediate post-exercise period and across the day is warranted to establish 
current practises, so that appropriate and practical recommendations can be 
provided to these athletes to optimise recovery.  
Summary 
The primary findings of this study support the hypothesis that an acute dose of 40 
g of whey protein isolate following a DHR can improve recovery of muscle function 
in older female endurance runners. The 40 g dose showed a likely small beneficial 
effect for attenuating decreases in MVC and improving CMJ height performance 
compared to 20 g of WPI or an isocaloric placebo at 24 h post-exercise. The 
observed benefits of 40 g of WPI, though not directly measured, are proposed to 
be from this larger dose of protein facilitating a greater repair and remodelling of 
the myofibrillar fibres and hence a more rapid improvement in the recovery of 
muscle function.  Improving the recovery of muscle function is relevant to older 
female endurance runners as it will allow these athletes to better maintain the 























The current study was designed to compare the effect of a higher (40 g) acute 
protein intake versus the recommended intake (20 g) immediately following 
muscle-damaging exercise in older female endurance runners on the recovery of 
muscle function, perceived muscle soreness, and flexibility within a 24 h period. 
The main findings of this research indicate that older female endurance runners 
benefit from the 40 g protein intake as compared to the recommended 20 g or 
placebo, for improving muscle function following exercise induced muscle 
damage. Relative to baseline measures 40 g of protein had a likely small beneficial 
effect compared to the placebo (ES = 0.24 ± 0.5) and 20 g of protein (ES = 0.25 ± 
0.29) for improving MVC at 24 h. Relative to baseline measures 40 g of protein had 
a likely small beneficial effect for improving CMJ compared to 20 g of protein at 3 
h (ES = 2.9 ± 4.9) and at 24 h compared to the placebo (ES = 0.32 ± 0.39) and 20 g 
of protein (ES = 0.27 ± 0.19). While this study had a small sample size, the trend 
for improving muscle function warrants further investigation with a larger number 
of older female endurance runners, given that an enhanced recovery would allow 
these athletes to better maintain the quality of work during subsequent daily 
bouts of training.  
Practical Applications 
The evidence of this research supports the use of a higher protein intake of 40 g 
to improve recovery of muscle function in older female endurance runners. These 
findings provide insight for recovery recommendations in this population after 
daily bouts of training, specifically intense training bouts where eccentric muscle-
damage is induced.  In practical terms, consuming 40 g of WPI post endurance 
running will help athletes better maintain the quality of work during subsequent 
training sessions, supporting training induced adaptations and ultimately 




relevant during intensified blocks of training when the older female endurance 
athlete needs to recover adequately before the next acute training bout. 
Future Research  
 A larger study to expand on the findings of the current study given the 
trend of improved muscle function seen in this pilot study. 
  Investigate if the modest beneficial effects seen with the higher acute 
protein intake on muscle function can be further enhanced with 
additional doses of protein evenly distributed over the day to accelerate 
the recovery process.  
 Determine the effects of chronic protein intake post-exercise during 
blocks of intense endurance training, on the ability to maintain a 
prescribed training program. 
 Chronic eccentric loading interventions to increase leg stiffness in older 
female endurance runners in the aim of improving performance and 
potentially reducing the risk of injury.  
 More comprehensive and well conducted nutrition assessments in this 
cohort. Assessment of the nutritional recovery practises in the immediate 
post-exercise period and across the day to establish current practise, and 
to provide appropriate and practical recommendations to optimise 
recovery. 
Limitations 
The small sample size of this study reduced statistical power, decreasing the ability 
to detect meaningful effects and reducing the external validity. The small sample 
size was due to difficulty in recruiting participants, with only six of the 19 
participants assessed for eligibility participating in the study. The main reasons for 
withdrawing from the study were having to abstain from coffee for the 24 h before 
trials, unable to commit to the time, and the study interfering with their training. 




does serve as a pilot study, with none of the six participants recruited withdrawing 
during the three weeks of trials and all 18 data sets analysed.  
Diet was not strictly controlled for in the study. Although there was a high 
compliance by individual participants in replicating their diets for the 48 h prior to 
the downhill runs and the 24 h post.  
Oestrogen levels were not measured or controlled for in the study. While all 
participants were of an age when oestrogen levels generally decline, levels would 
have been different due to the variation in participants menopausal status. With 
the small sample size of this study and differing oestrogen concentrations, it 
cannot be determined how muscle damage, recovery or the results of this study 
were influenced. Measuring oestrogen levels and recruiting a larger sample size of 
only postmenopausal female endurance runners, with stabilised hormone levels 
would provide more insight into the mechanisms responsible for the results 
determined in the current study.  
The inclusion of another functional test, such as measuring isokinetic MVC of the 
knee extensors, would provide another more valid assessment of muscle recovery 
from downhill running.   
Conclusions 
The current study has demonstrated that the acute ingestion of 40 g of whey 
protein isolate improves recovery of muscle function within 24 hours following 
muscle-damaging exercise in older female endurance runners. The data from the 
six participants indicates a trend for improving muscle function and warrants a 
larger study. This higher protein intake post-exercise may be advantageous to 
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Appendix 1 – Ethics approval letter 
 
The University of Waikato 
Private Bag 3105 
Gate 1, Knighton Road 






22 May 2018 
Human Research Ethics Committee 
Julie Barbour 












UoW HREC(Health)#2018-34 : Acute protein supplementation post exercise to enhance 
recovery in post-menopausal female endurance runners 
 
Thank you for submitting your amended application HREC(Health)#2018-34 for ethical approval. 
 
We are now pleased to provide formal approval for your study of the effect of protein supplements 
on recovery in post-menopausal women who are endurance runners. This will involve the following 
research activities: 
1. DEXA bone density test at Toi-Ohomai bone health lab 
2. Preliminary assessments (screening for readiness to exercise PAR-Q, training 
questionnaire), height and weight, food diary instructions and templates 
3. Familiarisation run and training trial (maximal voluntary contraction MVC), plus information 
around diet and training schedule around trials 
4. Trials x3, 3 weeks apart, including saliva samples, MVC measurements, consumption of 
supplement. Samples and MVC repeated at 3 hours and 24 hours after run. 
: 
Please contact the committee by email (humanethics@waikato.ac.nz) if you wish to make 
changes to your project as it unfolds, quoting your application number with your future 
correspondence. Any minor changes or additions to the approved research activities can be 
handled outside the monthly application cycle. 
 






Julie Barbour PhD 
Chairperson 




Appendix 2 – Introduction letter for potential participants 
 
Dear Club Member 
 
I am currently enrolled in a Master of Health, Sport and Human Performance at the 
University of Waikato. As part of my thesis and a partial requirement of my Masters, 
I am required to carry out a research project on a chosen topic, which is:  
 
“Acute protein supplementation post-exercise to enhance recovery in post-
menopausal female endurance runners” 
 
The primary objective of this study is to determine if higher than recommended 
acute protein supplementation after muscle-damaging exercise can enhance 
recovery in post-menopausal female endurance runners. Secondary, to the main 
aim is to gather nutrition data on the recovery practices of these athletes. 
 
This study is relevant for several reasons. The nutritional recovery practices of 
endurance athletes impact on the quality of subsequent training sessions, 
adaptations, and ultimately performance. Secondly, after muscle-damaging 
exercise, as with downhill running recovery is delayed in Masters athletes due to 
impairments in the synthesis of protein for the repair and remodelling of muscle. 
Higher than currently recommended doses of protein after resistance training in 
untrained older males, has been found to increase muscle protein synthesis. 
However, to date there is limited research on age specific protein feedings post-
exercise to enhance muscle recovery in Masters endurance athletes and none 
have included older female endurance runners.  
 
Your voluntary participation in this project would mean you would be involved in 
novel research. This research will provide valuable information where none 




menopausal female endurance runners, and secondly on the nutrient intakes and 
recovery practices of this cohort. Additionally, you will be provided with individual 
feedback on your nutrient intakes and recovery practices.  
 
If you are potentially interested in participating in this project, please contact me 
via email or phone and I will provide you with a Participant Information Sheet. 
Please take the time to read the sheet and feel free to contact me if you require 
further information.  
 
A meeting will then be held for all those interested in participating in the study at 
the University of Waikato Adams Centre for High Performance, Mount Maunganui, 
on ……… date, to go over the information sheet with you and answer any queries. 
Should you choose to participate, you will be required to read and voluntarily sign 
an informed consent form.  
 
Thank you 






Appendix 3 – Participant information sheet 
Participant Information Sheet 
 
Title of Project 
Acute protein intake post muscle-damaging exercise to improve 
recovery in older female endurance runners 
Project Purpose 
The primary purpose of this project is to determine if higher than recommended acute 
protein supplementation following muscle-damaging exercise can improve recovery in 
older female endurance runners. 
Secondary to the main purpose, the project will collect nutrition data on the recovery 
practises of older female endurance runners.  
Exclusion criteria from the study 
 Women who are less than 48 years of age 
 Endurance runners training for less than 5 hours per week or for a distance less 
than 10km in competition 
 On hormone therapy  
 Have cardiovascular disease or kidney disease, diabetes, arthritis or other joint 
injury of the lower body 
 Not able to consume whey protein 
 
Participant Involvement 
Preliminary assessments and familiarisation  
If you voluntarily sign the informed consent form, you will be asked to complete two 
questionnaires, a health screening questionnaire and a short training questionnaire. 
Measurements for height and weight will be taken.   Instructions will be given for keeping 
a food record diary (2 training days and 1 rest day) and a training log (approx. 15 mins a 
day to fill in diaries). The information from these records will be used for dietary and 
exercise training standardisation for trials and for collecting data on your nutrition intake 
and recovery practises. A familiarisation session for what is expected of you in the trials 
will then take place.  This will include instruction on the correct form for executing a knee 




flexibility and range of motion. These exercises are a measure of muscle function and 
recovery. To determine running speed for subsequent trials you will then perform a 30 
minute treadmill run at a -10% decline at 80% of your maximal heart rate. Heart rate and 
rate of perceived exertion will be monitored during this run. Time commitment 
approximately 90 minutes. 
 
Trial overview  
Three trials will be held a week apart the first commencing a week after the familiarisation 
session. Trials will be held in the morning and begin with baseline measurements of 
muscle function and muscle soreness. A 30 minute treadmill run, (-10% decline ~80% 
maximal heart rate) will follow. On completion of the run, muscle soreness and muscle 
function measurements will be taken. You will then be given either a placebo solution or 
whey protein isolate solution to drink. Muscle soreness and muscle function 
measurements will be retaken at 3 hours and 24 hours after the run.  
Dietary, Exercise and Additional Standardisation 
You will be asked to replicate your habitual diet for the 48 hours before each trial and 
during the 24 hours post run. Exercise training for the week prior to all three trials is to be 
kept the same/similar. In the 24 hours prior to each trial you will be asked to refrain from 
all exercise, alcohol, caffeine and non-steroid anti-inflammatory drugs (NSAID). In the 24 
hours post run you will be asked to refrain from taking NSAID, other supplements, or the 
use of other recovery modes (e.g. massage, compression garments). 
Location 
The University of Waikato Adams Centre for High Performance, Mt Maunganui, or the 
Avantidrome, Cambridge will be used for all preliminary assessments, familiarisation 
sessions and trials.  
Risk of Harm 
Measurements for height and weight will be taken in a private setting, with the correct 
terminology and language used. Weight or such will not be discussed with anyone. 
The most recent research supports the notion that consuming higher levels protein 
(2.5g/kg/day) than currently recommended (1-1.2g/kg/day) is unlikely to be harmful to 
your health. 
Precautionary measures have been put in place to minimise the risk of physical injury 
associated with the execution of a countermovement jump, knee extension and in the 
running component of this project.  Should an injury or an unforeseen medical condition 
occur, the researcher and research assistants (supervisor) are first aid certified, there is 




Use of Information Collected  
This research is a partial requirement for Master of Health, Sport and Human 
Performance. The information collected will be used in the researcher’s thesis. A printed 
and digital copy of the thesis will be publicly available through the University of Waikato. 
It is possible that journal articles and presentations may be the outcome of the research. 
Benefits from Participating  
Individual feedback will be given on dietary recovery practises, and once the study is 
concluded a summary of the findings will be available.  
 
Participation 
Your participation in this project is completely voluntary. Please take the opportunity to 
talk through your potential involvement with family and friends.  You have the right to 
have answered any questions about the project prior to signing the consent form and you 
are free to request further information at any stage during your participation. You are free 
to withdraw from the study up to two weeks after participating in the research activities, 
by informing a member of the research team, without disadvantage.  
Participant Privacy:  
Your data will not be recognised by name in text or analysis. Your information will be kept 
private and secure and only the researcher and supervisors will have access to this 
information.  On completion of the project all personal identifying information will be 
removed from paper records and electronic files which represent the data from the 
project, and these will be placed in secure storage and kept for at least five years. There 
is still a small risk of identification from this project, even with the de-personalisation of 
all identifying information.  
 
Further Inquiries 
If you have any questions or concerns regarding this project, either now or in the future, 
please feel free to contact either: 
Researcher: Zoe Neureuter                      e:  zoes1@xtra.co.nz            Ph: 027 310 
9580 
Supervisor: Dr. Stacy T Sims              e: stacy.sims@waikato.ac.nz 
Co-supervisor: Lillian Morton                  e: Lillian.Morton@hpsnz.org.nz 
This research project has been approved by the Human Research Ethics Committee 
(Health) of the University of Waikato under HREC(Health)#2018-34. Any questions about 




email humanethics@waikato.ac.nz, postal address, University of Waikato, Te Whare 




Appendix 4 – Consent form for participants 
Consent form for participants 
 
Title of Project 
Acute protein supplementation post-exercise to enhance recovery in 
post-menopausal female endurance runners  
Name of participant: …………………………………………. 
 
1. I have read the Information Sheet concerning this study and understand the 
aims of this research project. 
2. I have had sufficient time to talk with other people of my choice about 
participating in the study.   
3. I confirm that I meet the criteria for participation which are explained in the 
Information Sheet. 
4. All my questions about the project have been answered to my satisfaction, 
and I understand that I am free to request further information at any stage.  
5. I know that my participation in the project is entirely voluntary, and that I am 
free to withdraw from the project at any time without disadvantage. 
6. I have been informed and understand the nature of my participation 
7. I have been informed of any potential harm to me by taking part in this 
project. 
8. I know that when the project is completed all personal identifying information 
will be removed from the paper records and electronic files which represent 
the data from the project, and that these will be placed in secure storage and 
kept for at five years.  
9. I understand that the results of the project may be published and be available 
in the University of Waikato Library, and it is possible that journal articles and 
presentations may be the outcome of the research. 
10. I understand but that any personal identifying information will remain 
confidential between myself and the researcher and supervisors during the 




11. I know that with the de-personalization of all identifying information, there 
still is a small risk of identification from publications.  
12. I provide consent for the publication of research papers, presentations, 




This research project has been approved by the Human Research Ethics Committee 
(Health) of the University of Waikato under HREC(Health)#2018-34. Any questions about 
the ethical conduct of this research may be addressed to the Secretary of the Committee, 
email humanethics@waikato.ac.nz, postal address, University of Waikato, Te Whare 
Wananga o Waikato, Private Bag 3105, Hamilton 3240. 
 
 
Signature of participant:                                                                 Date: 
 






Appendix 5 – Participant training questionnaire 
Participant Training Questionnaire 
 
Name:   ……………………………………………... 
Age:   ………. 
Menopausal Status: (tick which applies to you) 
 Premenopausal: no decreased regularity in menstrual bleeding in last year 
 Early perimenopause: decreased menses regularity in previous three months   
 Late perimenopausal: no menses for last 3-11 months 
 Postmenopausal: no menses for 12 or more months 
Training:  
Endurance Running Training  
 Are you an endurance (tick all that apply) 
o Road runner 
o Trail runner 
o Both 
 What running distance do you train for (tick all that apply) 
o 10km 
o Half marathon 
o Marathon 
o Ultra 
 How many years have you been endurance running …………       
 In the last 3 months:  
o What is the average number of hours per week you run   ……… 




o Have you regularly (once or more a week) included hill work in your 
training yes/no 
 
        Resistance Training 
 Do you regularly (once or more a week) include resistance training (body 
weight, and/or with weights, not yoga) in your weekly training yes/no 
 If yes, in the last 3 months 
o What is the average number of hours per week you train   ……... 
o What is the average number of times per week you train   ……… 
 
Multiple training sessions in a day 
 Do you regularly (once or more a week) include two or more training sessions in 
a day in your weekly training yes/no  
 If yes in the last 3 months what is the average number of times per week you 
do two or more training sessions for 
o Running only  ………. 
o Running and resistance training   ………. 





Appendix 6- Food record diary package for participants: instructions, sample day 
and template 
Instructions for Completing Food Record Diary 
Please complete the food record diary for the three days before the first running trial, 
the day of the trial and the morning before retesting at 24 hours post run. If these three 
days do not include two training days (rest day is the day before the run trial) please 
include an additional day which is a training day. It is a good idea to carry the food record 
with you and record entries as soon after eating as possible. Don’t wait until the end of 
the day or you will forget. 
It is important for you to record ALL food and beverages you consume for meals or snacks 
at home or away from home. Please do not change your normal eating habits for the  
days of recording. Your honesty is crucial for collecting accurate data on the nutritional 
recovery practises of post-menopausal female endurance runners and for providing you 
with valuable feedback on your current nutrient intakes and recovery practises. 
Please include the following information for Day 1, Day 2 and Day 3 on your Food Record. 
 Date: fill in the section at the top of each page to indicate the date 
 Time: time the meal or snack was eaten 
 Meal: indicate if it was breakfast, lunch, dinner, a snack 
 Food Description: enter all foods and beverages consumed at a meal or snack. 
Please include if applicable: 
o Type of food: e.g. soy and linseed bread, timtams biscuits, canned tuna 
in water 
o Brand of food: e.g. Vogels, Arnotts 
o Cooking method: e.g. fried, poached, raw,  
o Homemade or Purchased: e.g. packaged supermarket, fast food, 
restaurant 
o Other relevant information: e.g. fat content: low-fat milk, lean beef, 
skinless and boneless chicken, flavour: chocolate milk, blueberry 
yoghurt  
 Amount: for every food or beverage you consume enter the amount using 
either 
o Common household measures: teaspoon, tablespoon, cup (metric cup = 
250ml) 
o Refer to volume or weight on food package  




o Estimate portion size: use either the grid (dimension and shape) or 
portion size guide provided 
NB: combination foods and mixed dishes please provide details and amounts of 
each food or include the recipe.  
If applicable, please state if the amount recorded is a raw or cooked amount. 
 Supplements: include any protein supplements you take: type (powder, bar, 
drink, brand, flavour and amount. Use the food label on the protein supplement 
to help provide details.  
Daily Check: please go over your entries at the end of the day to check you have included 





Food record - Sample Day 
Participant Name: 
Contact Details:  
Date: 
Time Meal  Description: include food/beverage amount, type, brand, 
cooking method, flavour, etc 
6am Pre-run  1 cup instant black coffee  
 Snack 1 home baked Anzac biscuit – 3cm diameter 
   
8 am Breakfast 1 cup plunger black coffee  
  2 slices Vogels soy and linseed toast 
  3 tsp Adams smooth peanut butter 
  1 tsp honey 
  ½ cup low fat unsweetened natural Greek yoghurt 
  ¼ cup Sanitarium natural muesli 
  ¼ cup frozen blueberries 
   
11 am Snack 1 cup light reduced fat trim (blue top) milk, 1 med banana 
   
1.30 
pm  
Lunch 1 large cup black tea, 1 med homemade Anzac bici 
  1 Freya’s wholemeal wrap 
  3 slices tasty cheese – business card size each 
  1.5 tsp Best Foods mayonnaise 
  1.5 tsp of homemade tomato relish 
  1 small tomato, 1 Tbsp alfalfa sprouts, 1 handful/1 cup salad 
greens 
   
5 pm Snack 1 medium orange, sm handful unroasted almonds, 1 Timtam 
bici 
  1 cup (250 ml) homemade kombucha tea 
   
7.45 
pm 
Dinner Frittata: 12 med eggs, 4 handfuls spinach, 2 medium 
tomatoes,  
  1 med sweet red pepper, 1 small onion, 2 med kumura,  
  1 cup grated tasty cheese, 4 slices Grandpas lean middle 
bacon  
  ¼ small pumpkin, 2 Tbsp olive oil      I ate ¼ of this frittata 




  ½ med tomato 1Tbsp of Paul Newman Balsamic dressing 





Food record template  
Participant Name:  
Contact Details:  
Date:                                             
 
Time Meal  Description: include food/beverage amount, type, brand, 
cooking method, flavour, etc 
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
NB: Please check that you have provided enough detail that if you gave this record 






Appendix 7 – Training log template 





Description of Training Intensity Finish 
Time      
     
     
     
     
     
     
     
     
     
     
 
Intensity of Training 
 Light: Requires little effort, can carry on a full conversation 
 Moderate: Requires a moderate amount of effort and noticeably 
accelerates the heart rate 
 Vigorous: Requires a large amount of effort and causes rapid breathing 




Appendix 8 – Advertisement poster 




“Acute protein supplementation post-exercise to 
enhance recovery in post-menopausal female 
endurance runners” 
Volunteers needed now to participate in 
this novel research study. 
Your participation will provide valuable information 
where none currently exists! 
This study is a partial requirement for a Master of Health, Sport and Human 
Performance at the University of Waikato 
 
For more information contact :  




Appendix 9 – Protein supplement composition 
Protein Supplements  
Brand: BALANCE: WPI vanilla flavour (B 14187) 
Nutrient analysis: quantity/100g  
 Protein: 87.8g (leucine 10.5) 
 Carbohydrate (CHO): 3.6 
 Fat: 0.7 
SUPPLEMENTS:  
 Volume: 250ml 
 Energy: ~ 1190 kJ 
 Matched for taste/colour/consistency 
40 g Protein Supplement: 40g P and 30g CHO 
 40g P/45.6g protein powder (leucine 4.8g) 
 1.6g CHO/ 45.6g p powder 
 10g CHO/ 10g Banana Nesquik 
 18.4g CHO/92g Banana 
20g Protein Supplement: 20g P and 50g CHO 
 20g P/22.8g protein powder (leucine 2.4g) 
 0.8g CHO/ 22.8g p powder 
 10g CHO/10g Banana Nesquik 
 10g CHO/10g Glucose 
 29.2g CHO/ 150g Banana 
CHO Placebo: 70g CHO 
 10g CHO/10g Banana Nesquik 
 25g CHO/25g glucose 
 35g CHO/ 175g banana 
 ⅛tsp Xanthan Gum (thickening agent) 




Appendix 10 – Supplement questionnaire 
SUPPLEMENT QUESTIONNAIRE 
 
Please tick which supplement you think you had for each trial. 
 
 Carbohydrate Protein 20 g Protein 40 g I Don’t Know 
     
Trial One     
Trial Two     
Trial Three     
 
 
Flavour: on a scale of 1-5 how well matched were the supplements for flavour? 
1 = totally different flavour   5 = no difference in flavour  
   
Texture: on a scale of 1-5 how well matched were the supplements in texture? 
1 = totally different texture   5 = no difference in texture 
 
Colour: on a scale of 1-5 how well matched were the supplements for 
appearance/colour? 
1 = totally different colour/appearance   5 = no difference in 
appearance/colour 
 
Palatability: on a scale of 1-5 how easy and enjoyable were the supplements to 
drink? 




Appendix 11 – Visual analogue scale for muscle soreness  
Visual Analogue Scale for Muscle Soreness 
Participant ID: ……………………………………..... 
Trial Number: …………….    
Measurement Period  
     Baseline                 0 hrs post exercise         3 hrs post exercise              24 hrs 




No muscle soreness                                                    Muscle soreness as bad as it                    
could possibly be 
Visual Analogue Scale for Muscle Soreness
Participant ID: ……………………………………….. 
Trial Number: …………. 
 Measurement Period  
     Baseline                 0 hrs post exercise         3 hrs post exercise              24 hrs 




No muscle soreness                                                                           Muscle soreness 






Appendix 12 – Physical activity readiness questionnaire  
 
Par Q Form 
 
Name:  Date:    
Telephone:    
Date of Birth:  Age:    Height:    Weight:   
In Case of Emergency Contact:  Relationship:   
Address:    
Physician:    
Phone:    
Specialty:    
Address:    Phone:    
Are you currently under a doctor’s care:  Yes No 
If yes, explain:    
When was the last time you had a physical examination?    
Have you ever had an exercise stress test: Yes       No       Don’t Know If 
yes, were the results:  Normal     Abnormal Do 
you take any medications on a regular basis?   Yes No 
If yes, please list medications and reasons for taking:    
Have you been recently hospitalized?  Yes No 
If yes, explain:    
Do you smoke? Yes         No 
Are you pregnant? Yes         No 
Do you drink alcohol more than three times/week? Yes         No 
Is your stress level high? Yes         No 
Are you moderately active on most days of the week? Yes No 
Do you have: 
High blood pressure? Yes         No 
High cholesterol? Yes         No 
Diabetes? Yes         No 
Have parents or siblings who, prior to age 55 had: Yes         No 
A heart attack? Yes         No 
A stroke? Yes         No 






To the best of my knowledge the above information is true 
Signature _____________________ 
Date _________________________                     Witness _______________________ 
 
